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1.INTRODUCTION 
The National Institute of Siddha was started on 30
th
 October 2004 and Department of 
Gunapadam is also functioning from that date and doing continuous drug research. This study 
is about the toxicological and pharmacological evaluation of Seenthil chooranam on wistar 
albino rat models. Standard operative procedure (SOP) was followed. All the ingredients 
were reviewed for it importance in this formula towards eliciting pharmacological actions. 
The Seenthil chooranam was selected from the authentic book list Agasthiyar 
paripuranam 400 and it was subjected into analysis (physiochemical and chemical), it fulfills 
all the standardization parameters of chooranam as mentioned in AYUSH guidelines 
 
Review of literature in various categories was carried out. Siddha aspect, botanical 
aspect, lateral research and pharmacetical aspect revealed about the drug and the disease, 
which strongly support that it possesses Antidiabetic and Hepatoprotective, for that purpose it 
has been selected for this study. 
 
The human clinical dose of Seenthil chooranam was converted in to animal dose by 
using standard method suggested by Pharmacologist. Based on OECD 423 the trail drug 
Seenthil Chooranam was studied and it is non toxic up to the dose of 2000mg/kg. Gross and 
histopathological examination of organs of animals administered with highest dose showed 
normal histological architecture. This could be confirmed as no-observed-adverse-effect level 
(NOAEL) on acute, 28 days repeated oral and 90 days repeated oral toxicity studies. 
 
The Seenthil chooranam is being used for various therapeutic conditions in siddha 
system of medicines. This study also proved the following pharmacological activities. 
 
Antidiabetic, Hepatoprotective and Anti-Inflammtory activity of SEENTHIL 
CHOORANAM was scientifically validated.  
 
So, this medicine can be included in the therapeutic intervention.  
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                                               2. AIM AND OBJECTIVES 
 AIM 
 To evaluate the safety and pharmacological profile of the test drug “SEENTHIL 
CHOORANAM’’ in animal models. 
OBJECTIVE: 
 Review of various information relevant to the study from Siddha and modern 
literature. 
 Preparation of the drug according to the classical Siddha literature. 
 pharmacognostical study of the test drug 
 Physicochemical, Chemical and phytochemical analysis of test drug. 
 
 
 Toxicity studies: 
 Acute oral toxicity study by   OECD – 423 Guideline. 
 Repeated dose 28 days oral toxicity study by OECD – 407Guideline.  
 Repeated dose 90 days toxicity study by OECD – 408 Guideline 
 
 Pharmacological activities in Wister albino rats  
 Antidiabetic activity by Steptozotocin induced method. 
  Hepatoprotective activity by CCl4 induced hepatotoxicity method 
 Anti-inflammatory activity by Carrageenan induced paw edema method 
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3.REVIEW OF LITERATURE 
3.1 GUNAPADAM ASPECT 
rPe;jpy; - Seenthil 
 
NtWngaH  : mkpHjty;yp 
Nrhkty;yp  
mkpHij 
mkpHjf;nfhb  
Fz;lyp. 
Botanical name : Tinospora cordifolia (Willd.) 
    
English name  : Heart leaved moon seed 
Family name  : Menispermaceae 
gad;gLk; cWg;G : 
,iy 
nfhb 
NtH (fpoq;F) 
 
Rit  : ifg;G> 
jd;ik : ntg;gk;> 
gpupT  : fhHg;G 
 
nra;if  
clw;Nww;wp                    
fhkk;ngUf;fp         
cs;soyhw;wp           
grpj;jPj;J}z;b              
cukhf;fp                  
rpWePh;ngUf;fp      
nghJf;Fzk;    
'mkpHjty;yp Nrhkty;yp ahk;ngEQ; rPe;jpy; 
epkHfrg;Ngh Ll;bzK Neuhk; jpkpHjpdKk; 
Fl;lk; RuNkfk; nfhJk;Gup Kj;Njhlk; 
el;lkwe; NjFk; ele;J  (mfj;jpaH itj;jpa rpe;jhkzp 4000.ghfk;2) 
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nghUs;  
cl;bzk;> jpkpH> jpdT> Fl;lk;> Ruk;> Nkfk;> jpupNjhlk; Kjypad jPUk;. 
 
kUj;Jtg; gad;fs;  
mKjty; ypf;nfhb af;fhu Kz;blj; 
jpkpUW NkfNeha;j; jPnayh khWNk (Njud;. ntz;gh) 
nghUs;  
rPe;jpw;rHf;fiuahy; iffhy; jpkpH> Nkfntl;il tpyFk; 
 
NkfnkD khjgj;jhy; nte;j TapHg;gapiuj; 
jhf klq;ffj; jzpj;jyhy; Mfk;. 
Mku nuzypUf;f thjupj;j yhNy 
mKjty;yp rQ;rPtp ahk;   (Njud;. ntz;gh) 
nghUs;   
rPe;jpy; kJNkfnkd;Dk; ePupopT NehapYz;lhFk;. ePH Ntl;ifia jzpf;Fk; 
 
nfhb 
Kw;wpa nfhbNa ew;gad; jUk;. ,jdhy; cly; td;ik ngWk;. 
,f;nfhbapypUe;J vLf;Fk; cg;Gf;F rPe;jpw; rHf;fiu vd;gJ ngaH. rPe;jpy; 
rHf;fiuia Ruq;fspw;F gpd; Vw;gLk; cly; ,isg;gpw;Fk;> kz;zPuy; tPf;fk; my;yJ 
typ> fhkhiy> ,Uky>; %H;r;ir> the;jp> Nfhiof;fl;L MfpaitfSf;F toq;fyhk;. 
 
rPe;jpy; rHf;fiu 
Fl;lk; gjpndl;Lk; FQ;ruj;jpd; Nwhw;nrhwpAq; 
fl;lk; ngupjhq; faNehAk; gl;lTld; 
nre;jPKd; gQ;nrdNt rPe;jYg; Nghlise;j  
je;jh tsePHf;Fr; rhk;.     (Njud; ntz;gh) 
gjpndz; tifahd Fiw Neha;fSk;> ahidj;Njhy; Nghd;w nrhwpAk;> nfhba 
fgg;gpzpfSk; rPe;jpy; cg;igf; nfhLf;fpy; xopAk;. 
 
rPe;jpw; rHf;fiu nra;Ak; Kiw 
ed;wha;,bj;j rPe;jpw; nfhbia FspHe;j ePupypl;L kW ehs; file;J 
jpg;gpiiaf; frf;fpg;gpope;J ePf;fp ntapypy; ,uz;L my;yJ %d;W kzpNeuk; itf;f 
ePH njspAk;. me;j ePiu ,Wj;J tpl;L NtW ePH tpl;Lf;fyf;fp Nkw;fz;lgbNa ePiu 
,Wj;J Rz;ltpl;L kWgbAk; Nkw;gbahfNt nra;J ePiu ,Wj;J tpbd; 
mbapw;gbe;jpUf;Fk; khNt rPe;jpw; rHf;fiu vdg;gLk;. 
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 fhpryhq;fz;zp - Karisalankanni 
 
NtWngaH : fhprhiy  
ifNfrp 
fhparhiy  
gpUq;fuh[k; 
ifahd; 
Njfuh[k; 
ifahe;jfiu 
 
Botanical name : Eclipta Prostrata, Linn. 
 
English name  : false daisy 
 
Family name  : Asteraceae 
 
gad;gLk; cWg;G : G+z;L 
 
Rit  :  ifg;G 
jd;ik :  ntg;gk; 
gpupT  : fhHg;G 
 
nra;if   : gpj;jePh;g;ngUf;fp 
cukhf;fp    
clw;Nww;wp 
<uy;Njw;wp 
ePh;kyk; Nghf;fp 
nghJf;Fzk; 
 
Fuw;fk;kw; fhkhiy Fl;lnkhL Nrhig 
Aww;ghz;L gd;Ndh nahopa epuw;nrhd;d 
nka;ahe; jfiunahj;j kPdp z;Z ew;Gyj;Jf;  
ifahe; jfiunahj;jf; fhy;.   (mfj;jpah; Fzthflk;) 
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Fzk;    
,jdhy; FuYWg;G> Neha;> fhkhiy> Fl;lk;> tPf;fk;> ghz;L> gy;Neha; 
Mfpait Nghk;. clypw; nghw;rhaYk; Mspf;Fs;s gyKk; cz;lhFk;. 
 
kUj;Jt gad;fs;  
 
 fupryhq;fz;zpr;rhW 1 gq;Fk; >Mkzf;F nea; 1 gq;Fk; fye;J mjpw;nfhQ;rk; 
nts;isg; G+z;il NrHj;J vupj;J> gjj;jpy; tbj;Jf; nfhz;L> Ntis 
xd;Wf;F 15fpuhk; Kjy; 30fpuhk; vil  tiuapw; nfhLf;f fha;r;rw;fl;b> 
tPf;fk;> fhkhiy> Fl;lk; ,it ePq;Fk;. 
 
 fuprhiyr; R+uzj;ij mar;nre;J}uj;jpw;F mDghdkhff;nfhs;s ghz;L> 
Nrhig> fhkhiy Kjypa Neha;fs; jPUk;.  
 
 Nkw;gbr;rhW 2Jsp vLj;J> 8Jsp Njdpw; fye;J nfhLf;f> iff;Foe;ijfl;F 
cz;lhFk; ePHf;Nfhit ([yNjhrk;) ePq;Fk;. 
 
 ,jid ey;nyz;izapy; miuj;J>ahidf;fhy; Neha;f;F NkYf;Fg; g+ryhk;. 
%j;jpuj;jpy; ,uj;jk; fz;lhy; > ,iyr;rhW>fhy; Kjy; miu Mohf;F tPjk; 
jpdk; ,UNtis nfhLf;fj; jPUk;. 
 
 ,iyia miuj;Jf; fw;fk; gz;zpj; Njs;fbf;F> fbj;j ,lj;jpy; ed;wha; 
Nja;j;J> mijNa mt;tplj;jpy; itj;Jf;fl;bdhy; eQ;R ePq;Fk;.,iyia 
Ntfitg;gjhYz;lhd Mtpia %y Neha;fSf;Fg; gpbf;f jPUk;. 
 
 NtHg;nghbj;jij fy;yPuy; kz;zPuy; Neha;fspw;Fk; Njhiyg;gw;wpa 
gpzpfSf;Fk; nfhLf;fyhk;1. 
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G+ehfk; - Earthworm 
NtW ngaH  : ehf;Fg;G+r;rp 
 G+kpNtH 
 ehq;$o;GO 
 kz;Rke;j thRfp 
 fz;lgjk; 
,J rJg;G epyq;fspy; mjpfkhff; fpilf;fpd;wJ. ,jpy; ,Utif cz;L. 
xd;W rptg;G epwj;ij cilaJ. kw;nwhd;W ntspwYld; $ba rptg;G epwj;ij 
cilaJ. ,tw;Ws; Kd;dJ rpwe;jJ. ,jpy; nrk;G rj;J ,Uf;fpd;wJ. ,J #l;il 
jUk.; twl;rpia cz;L gz;Zk; ,jd; Fzj;ij fPo;r; nra;Ashy; czuyhk;. 
 
  “khjtW nra;twl;rp khWklq; fhr;re;jp 
  ghjtW NehNahL ghWkly; - thjthW 
  Fz;lgjkPS Nkhf;fhs ikaKk;Nghq; 
  fz;l gjnkDq; fhy;” 
nghUs;   
G+ehfj;jpdhy; kpfTk; Jd;gj;ij tpistpf;fpd;w jhf NuhfKk; vOtpj 
mrhj;jpa re;epghj Ruq;fSk; NghFk;. CU]; jk;gk; vd;fpw kfhthjkhfpa 
Gypapdhy;> ftHe;J nfhs;sg;gl;l njhilahfpa cWg;G kPStNjhL Xf;fhsKk; 
fgNehAk; xopAnkd;f. 
 
Rj;jp 
,g;G+r;rpfisg; ghypy; tpl;lhy; ghiyaUe;jp kz;iz ff;fptpLk;. Gpd;G 
vLj;Jf;nfhs;tNj Rj;jp. G+r;rpfs; kPJ Rz;zhk;G ePH njspf;f clNd ,we;J tpLk;. 
Nkw;$wpathW Nkhupypl;L vLg;gpDk; Rj;jpahk; 
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cgNahfk; 
o ehf;Fg; G+r;rpia Rj;jp nra;J cyHj;jpr; #uzpj;J nfhbKe;jpupif 
gor;rhw;wpy; %d;W tuhfndil (12.6 fpuhk;) NrHj;Jf; Fbf;f fy;yilg;G 
>ePuilg;G clNd ePq;Fk;.  
o ,jid khkprq;fspd; ,urj;jpy; fye;J G+r> mz;lthjKk; mz;lg; 
Gz;Zk; ePq;Fk; >gpurt Ntjidia ePf;Fk;.  
o ehf;Fg;G+r;rpia vs; vz;nzapypl;Lvupj;Jf; Fbf;f ehl;gl;l ,UkiyAk; 
njhz;iltypiaAk; ePf;Fk;. 
o ,jid gr;iraha; miuj;Jg;G+r mWe;j euk;Gfs; $Lk;. ,j;Jld; 
fUq;fy;iyr; Rl;L NrHj;jiuj;Jg;G+r ,J %l;Lg; gprFfis rPHg;gLj;Jk;. 
mbgl;ljpdhy; ciwe;j cjpuj;ij fiuf;Fk;2. 
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3.2 BOTANICAL ASPECT 
Tinospora cordifolia - Seenthil 
 
Botanical Name  : Tinospora cordifolia (Miers.) 
Family   : Menispermaceae  
Vernacular names   
Tamil   :  Shindil-kodi 
English   :  Moonseed, Heartleaf, 
 Singala  :  Rasakinda  
Sans   :  Guduchi 
Hind   :  Gurach 
 
Parts used   :  Stem
3
 
Organoleptic charcter  
Taste  : Bitter 
Nature  : Hot 
Division : Hot 
Actions  : 
Hepatoprotective 
Antidiabetic 
Diuretic 
Stomachic 
Stimulates bile secretion
4
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Phytochemistry   
Tinospora cordifolia have different classes of chemical constituents such as alkaloids, 
diterpenoid lactones, glycosides, steroids, sesquiterpenoid, phenolics, aliphatic compounds 
and polysaccharides 
Stem & Root  : Alkaloids 
Berberine, Choline, Tembetarine, Magnoflorine, Tinosporin, Palmetine, Isocolumbin, 
Aporphine alkaloids, Jatrorrhizine, Tetrahydropalmatine, 
Stem   :  Glycosides    
18-norclerodane glucoside, Furanoid diterpene glucoside, Tinocordiside, 
Tinocordifolioside, Cordioside, Cordifolioside Syringin,  Syringin- apiosylglycoside, 
Pregnane glycoside, Palmatosides, Cordifolioside A, B, C, D and E 
Stem & Aerial plant :  Steroids  
β–sitosterol, δ-sitosterol, 20 β-hydroxyecdysone, Ecdysterone, Makisterone A, Giloinsterol5. 
 
Medicinal Uses  
 The stem juice is useful in diabetes, 
 The stem is bitter, stomachic, diuretic, stimulates bile secretion, causes constipation, 
allays thirst, burning sensation, vomiting, enriches the blood and cures jaundice.  
 The stem is widely used in diabetes, liver disorders and jaundice6. 
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Eclipta alba - Karisalankanni 
  
Botanical Name  : Eclipta alba.Hassk 
Family   : Asteraceae 
Vernacular names   
Tamil   :  Kaikeshi; Karisha-langanni 
English  :  False daisy 
Singala  :  Keekirindiya 
Sans   :  Kesharaja 
Hind   :  Mochkand    
Parts used   :  Whole plant 
 
 
Organoleptic character 
 
  Taste  : Bitter 
  Nature  : Hot 
  Division : Hot 
 
 
Actions   :  
Tonic, 
Cholagogue 
Alterative 
 Hepato- tonic 
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Phytochemistry  
Leaves 
Wedelolactone, desmethywedelolactone, desmethylwedlolactone-7-glucosidde, stigmasterol 
 
Roots  
Hentriacontanol, heptacosanol & stigmasterol, ecliptal,eclalbatin. 
 
Aerial parts 
Β–amyrin&luteolin-7-0-glucoside, apigenin, cinnaroside, sulphur compounds,eclabasaponins 
I-VI 
 
Stems 
wedelolactone 
 
Seeds 
Sterols, ecliptalbine(alkaloid) 
 
Whole plant 
Resin, ecliptine, reducing sugar, nicotine, stigmasterol, triterpenesaponin, eclalbatin, ursolic 
acid,oleanolic acid
7
. 
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Earthworm 
Scientific classification 
Kingdom : Animalia 
Phylum : Annelida 
Class  : Clitellata 
Subclass : Oligochaeta 
Order  : haplotaxida 
Family  : Eudrilidae 
Genus  : Eudrilus 
Species : E.eugeniae
8
. 
 
General information 
 Earthworms are primary animal biomass in the soil. The importance of earthworms in 
ecology and medicine has been increasingly felt amongst researchers. More than 200 
varieties of earthworms found in India, only 3 species are popular one among are Eudrilus 
eugeniae
6i
.Earthworms have been used in medicine for various remedies since 1340 AD
9
. 
Extracting medicinal compounds from the earthworm has traditionally been practiced by 
indigenous people throughout the world, more particularly in Asia
10
.Earthworm has been 
recognized in oriental medicine as anti- inflammatory, analgesic and antipyretic agent
11
 It 
shows anticancer effect by preventing excess glucose uptake
12
. Earthworm surface excreta 
were found to have potent antimicrobial activity
13
. It is also having anticoagulatory or 
fibrinolytic activity which results in the facilitation of blood circulation
14
 the earthworm has 
been suspected to contain proteases which dissolve the fibrin clots or anticoagulants which 
selectively interfere with the intrinsic pathway of blood coagulation cascade
15
. 
 
Traditional uses 
It posses copper element and also produce heat and dryness to the body. It is known to 
have Thirst, Fever, Backache nausea and Respiratory disorder 
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3.3 LATERAL RESEARCH 
Tinospora cordifolia 
Acute toxicity study  
The aqueous extract of T. cordifolia was administrated orally in increasing dose up to 800 
mg/kg. The rats were observed continuously for 2 h for behavioral, neurological, and autonomic 
profiles and after 24 and 72 h for any lethality. Acute toxicity studies revealed that the nontoxic nature 
of the aqueous extract of T. cordifolia. There was no lethality or toxic reaction found at any doses 
selected until the end of the study period
16
. (Kumar et al., 2013) 
Pharmacological studies 
Anti diabetic activity:  
Oral administration of an aqueous T. cordifolia root extract to alloxan diabetic rats 
caused a significant reduction in blood glucose and brain lipids. Though the aqueous extract 
at a dose of 400 mg/kg could elicit significant anti-hyperglycemic effect in different animal 
models, its effect was equivalent to only one unit/kg of insulin
17
. 
Ethanolic extracts of Tinospora cordifolia leaves in different dosages (200 and 400 
mg/kg)Administered orally for 10 days and 30 days in streptozotocin diabetic albino rats. 
Present study clearly showed that TC has significant antidiabetic activity in diabetic animals 
and has an efficacy of 50% to 70% compared to insulin
18
. (Shekhar Singh et. Al) 
 
Hepato protective 
The study reported the Different extracts of Tinospora cordifoliaagainst carbon 
tetrachloride (CCl4) induced liver damage in rats. It shows significant hepatoprotective 
activity
19
. (Kavitha B.T. et al., 2011) 
Anti-inflammatory Activity  
The aqueous extract of T. cordifolia exerted a significant anti-inflammatory effect on 
cotton pellet granuloma and formalin induced arthritis models. The dried stem of T. 
cordifolia produced significant anti- inflammatory effect in both acute and sub acute models 
of inflammation
20
. 
15 
 
Another study shows that the water extract of the stem of Tinospora cordifolia has 
been checked for anti-inflammatory activity in albino rats. It has significantly inhibited acute 
inflammatory response evoked by carrageenin when administered orally and 
intraperitoneally
21
. 
 
Eclipta prostrata  
Toxicity report 
Acute toxicity study  
The observation of acute toxicity study indicated that there was no death in 
2000mg/kg dose after 72hr
22
. (Mishra et al) 
Pharmacological activity 
Anti-inflammatory 
The methanolic extract of leaves of Eclipta prostrata Linn was reported for anti-
inflammatory activity in albino Wistar rats. The results lend support to the traditional use of 
E. prostrata in the treatment of inflammatory diseases
23
. (Arunachalam et al., 2009) 
The anti-inflammatory effect of the plant of Eclipta alba was evaluated on acute and 
chronic phase inflammation models in rats. The results indicate the potent anti-inflammatory 
effect and therapeutic efficacy of Eclipta alba extract on animal models, which is compared 
with Indomethacin
24
. 
 
Antihyperglycemic Activity 
This study found that Oral administration of leaf suspension of E. alba (2 and 4 g/kg 
body weight) for 60 days resulted in significant reduction in blood glucose it possess potent 
antihyperglycemic activity
25
. 
Hypoglycemic activity 
The methanolic extract of Eclipta alba in alloxan induced diabetic model in albino rats 
was reported significant reduction in serum glucose
26
. (Hemalakshmi et.al., 2012) 
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Hepatoprotective study 
The effect of Eclipta alba (EA)extract was studied on paracetamol induced hepatic 
damage in mice treatment with 50% ethanol extract of E.alba was found to protect the the 
mice from hepato-toxic action of paracetamol as evidenced by significant reduction in the 
elevated serum transaminase levels. Histopathological studies showed marked reduction in 
fatty degeneration
27
.  
 
Another study was carried out to investigate the possible protective effect of leaf 
extract of Eclipta alba on paracetamol induced toxicity in liver. This study elucidated that 
eclipta alba has Significant hepatoprotective activity against paracetmol induced rat
28
. (K. 
Prabu et al., 2011) 
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Earthworm 
Toxicity evaluation 
The acute toxicity effects of earthworm powder (EWP) obtained from Eudrillus 
euginae on wistar male rats. The animals are treated orally with EWP at the doses of 100 
mg/kg, 200mg/kg and 300mg/kg daily for 12 days The EWP did not show any significant 
effect in clinical signs, behavioral changes and histopathological studies
29
. (Jaganathan 
Anitha et al., 2012) 
 
Pharmacological activity 
Anti-inflammatory activity 
Various solvent extracts of an earthworm, Eudrilus eugeniae were reported for anti-
inflammatory activity
30
. (Mathur et al., 2011) 
 
Haemostatic activity 
Homeostasis represents the balance between the process of coagulation and 
fibrinolysis. In this study the earthworm powder (glycolipoprotein mixture) from Eudrilus 
eugeniae was extracted and tested for its haemostatic effect in Wistar rat model. It indicating 
a decrease (p< 0.05) in clotting parameter compared to its control
31
. (Anjana.J.C1, 
Sruthy.P.B) 
 
Anticancer Potentials 
 The coelomic fluids of Eudrilus eugeniae reportedto have the Cytotoxic effect so 
which can be useful in the treatment of cancer
32
. (Dinesh et al., 2013) 
Antimicrobial Activity 
The paste prepared from earthworm, Eudrilus eugeniae was tested for the 
antimicrobial screening the study clearly found that the paste contain a good antibacterial 
potential and the bioactive compounds to inhibit the growth of bacteria and fungi
15i
. 
(Vasanthi et al., 2013) 
 
Another study of earthworm, Eudrilus eugeniae was reported. It was found that 95% 
ethanol extract of earthworm was potent antibacterial agent against Streptococcus pyogens 
and antifungal agent against Candida albicans
33
. (Abhishek Mathur et al., 2010) 
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3.4 PHARMACEUTICAL REVIEW 
CHOORANAM 
Definition 
 Chooranams are fine dry powders of a single drug or a mixture of two or more drugs, 
which are powdered separately prior to their being, mixed to homogeneity. The chooranam 
should be fine and should be never damp. The finesses of the sieve should be 100 mesh or 
still finer. Chooranams retain their potency for 3 months
34
. (Siddha Pharmacopoeia of India) 
Purification of the chooranam 
jhndd;w #uzj;jpd; Rj;jpf;NfS 
      jg;ghNj ruf;nfy;yhQ; #uzpj;J 
ehndd;w thtpd; ghyhw; gpire;J 
      eykhd rl;bapNy ghiytpl;L 
thndd;w Rj;jryk; ghjptpl;L 
      tskhf Nkw;rPiy NfhL fl;bg; 
ghndd;w #uzj;ijg; gpl;LNghy; itj;J 
      gjwhnj nte;njLf;fr; rpj;jpaNk!35 
                     mf];jpau; itj;jpa ,uj;jpdr; RUf;fk;.   
The prepared chooranam is first mixed with the milk, and then taken a pot fill with 
half quantity milk and half quantity water. The mouth of the pot is covered with a thin cloth 
material. Over the cloth the placed mixed chooranam. The pot is placed over the stove and 
heated. 
Storage 
The prepared chooranam should be allowed to cool by spreading and mixing, prior to 
packing. They should be stored in tightly stoppered glass, polythene or tin containers, or in 
polythene or cellophane bags and sealed. These bags should in turn be enclosed in cardboard 
boxes. 
The chooranam to facilitate easy handling and to assure exact dosage administration 
could be pressed into tablets with the addition of a suitable binder. These tablets could be 
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packed in bottles or tubes made either of glass or plastic or packed in strip of metal foil or 
plastic sheets. 
Then chooranam is said to retain its potency for 2 months and then gradually 
deteriorate. However if properly packed & stored they keep good for an year
36
. (Formulary of 
Siddha Medicines, 1993) 
According to AYUSH guidelines shelf life of chooranam is one year
37
. 
 
   
Material & Methods 
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4.MATERIALS AND METHODS 
PREPARATION OF THE SEENTHIL CHOORANAM:  
rPe;jpy; #uzk; 
MfhJ apd;dnkhU #u zq;Nfs; 
 mg;gNd rPe;jpAl #uzj;ij 
thfhf Rj;jfq;if jd;dpy; Rj;jp 
 ike;jNd %NtO junk nra;J 
ghfhf cyHj;jpaijghy;tpl; Lg;gp rpwpa 
 ghyfNd fhaitj;Jg yk;gj; jg;gh 
Neuhf fuprhiy# uzq;$l;b  
 epidthf G+ehfg; g+r;rpjid 
,d;ndhUtif #uzj;ijf; Nfl;ghahf mJ rPe;jpy; #uzkhFk;. rPe;jpy; 
J}aePupy; ,Ugj;jp xUKiw fOtp Rj;jp nra;J nfhz;L cyHj;jp ghy;tpl;L gprwp 
fhaitf;fTk;. mt;thW fha itj;J gj;Jgyk; epWj;J  vLj;jf; nfhs;sTk;. mNj 
msT fupryhq;fz;zp #uzj;ij mj;Jld; NrHj;J vLj;Jf; nfhs;sTk;. 
jd;idNa ghypyplkz; nzy;yhq; ff;Fe; 
 jUthfg; gpd;Gyh;j;jpr;#u zNk nra;J 
xz;ZNk gy%d;W, ilAq;$l;b  
 cj;jkNd %d;Wtif nghbj;J tbfl;b 
G+ehfj;jpid ghypy; ,l kz;iznay;yhk; ff;Fk; ,jidg; gpope;J ntapypy; 
cyHj;jp %d;Wgyk; vLj;Jf; nfhz;L tif ruf;FfisAk; fye;J nghbj;J tb 
fl;bf; nfhz;L ntUfb msT nea;apy; rhg;gpl Nkfk; <is> fhrk;> ,is  
Vuz;lthA jPUk;. 
thAntd;w thjnkhLt ul;rp gpj;jk; 
 tifahf jPUklh Njdpw;nfhs;s 
NjAntd;w fHkNeha; ehfg; Gz;fs; 
 Njhiyahj gPdprKk;njh iye;J NghFk; 
ghAnkd;w rHf;fiuapw; nfhz;lhy; ike;jh 
 ghq;fhd kapHntl;Lk;G Ontl; NlhLq; 
fhankd;w fhw;gpyKq;fz;nj spT Kz;lhq; 
fUthfg; Gspg;GifAe;j tpHf;f nrhy;Ny. (mfj;jpah; ghpG+uzk;-400) 
thjk;> tul;rp> gpj;jk; Mfpad jPUk;. ,r;#uzj;ij fHkNeha; >ehfg;Gz;fs;> 
gPdprk; Mfpad jPUk;. rHf;fiuapy; rhg;gpl kapH ntl;Lk; GOntl;Lk; jPUk;. fhy; 
gyKk; cz;lhFk;. Gspg;G Gif Mfpatw;iw jLf;fNtz;Lk;. 
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4.1. SOP for preparation of Seenthil chooranam 
The test drug Seenthil Chooranam (Chooranam = one of the 32 types of internal 
medicine), mentioned in classical siddha text Agasthiyar Paripuranam – 400, has been used 
for Megam (Diabetic mellitus), Eelai (Tuberculosis), Kasam (Cough), Elaipu (Bronchial 
asthma), Eranda vayu (Scrotal swelling). The ingredients of this formulation are  
Seenthil (Tinospora cordifolia)  - 10 palam (350gm) 
Karisalai (Eclipta Alba)  - 10 palam (350gm) 
Earthworm (Eudrilus eugeniae) -   3 palam (105mg) 
Procurement of Raw Drugs 
 The plant materials were collected from Tambaram sanatorium and Earth worm was 
collected at Thiruthani Agriculture farm Tamilnadu. 
Identification and Authentication of Raw Drugs 
The Herbs were Identified and authenticated by competent authority department of 
Gunapadam, National Institute Of Siddha and the Earth worm was identified & authenticated 
by Head, P.G. & Research Department of Zoology Govt. Arts College, C. Mutlur, 
Chidambaram. 
Purification process  
1. Seenthil: 
Peel off the outer skin of the stem and powdered, then washed it for 21 times in pure 
water and dried then sprinkled cow’s milk allow drying it  
2. Karisalai: 
Wash the whole plant and dry it in sunshade& powdered 
3. Poonagam: 
Soaked Earth worm Butter milk for a while to spit out mud then sprinkled lime water 
over it to kill then dry and powdered 
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Method of Preparation: 
The above purified three ingredients were powdered individually and mixed together 
and stored & preserved in an air tight container. 
 
Labelling 
   
Name of the preparation : Seenthil Chooranam 
Dose    : 1 gm bd 
Adjuvant/Vehicle  : Ghee 
Indications  : Megam (Diabetic mellitus), Eelai (Tuberculosis),    
Kasam (Cough), Elaipu (Bronchial asthma), Eranda 
vayu (Scrotal swelling) 
Date of expiry   : 1 year from the date of manufacture 
Therapeutic administration of drug 
Form of medicine  - Chooranam 
Route of administration - Oral 
Dose    - 1gm twice daily 
Vehicle   - Ghee 
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Ingredients of the Drug 
 
SEENTHIL 
(Before purification) 
Figure 1.1                                           
 
SEENTHIL 
(After purification) 
Figure 1.2 
 
KARISALAI 
(Before purification) 
Figure 1.3                                         
 
KARISALAI 
(After purification) 
Figure 1.4                                          
 
EARTHWORM 
(Before purification) 
Figure 1.5                        
 
                  
 
EARTHWORM 
(After purification) 
Figure 1.6           
                             
24 
 
Seenthil Chooranam (SC) 
 
Figure no: 1.6 
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4.2 ANALYTICAL STUDIES 
ANALYTICAL STUDIES OF SEENTHIL CHOORANAM BY AYUSH GUIDELINES 
Standardization of the drug brings the validation to be used as a medicine by 
subjecting the drug into many analysis and determining its quality and effectiveness. 
Standardization includes many studies such as its organoleptic character,  physico chemical  
characteristics studies and  determination of phytochemical properties inorder to assess the 
active principles and elements present in the drug. Thus standardization brings the efficacy 
and potency of the drug. 
 
Standardization of the drug includes: 
 
o Pharmacognostic studies 
 
o Physicochemical analysis 
 
o Chemical analysis 
 
o Heavy metal analysis 
 
o Elemental analysis 
 
o Particle size analysis 
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4.2.1 PHARMACOGNOSTIC STUDIES OF SEENTHIL CHOORANAM 
The pharmacognostical study was done at Captain Srinivasamurti Reseach Institute 
for Ayurveda and Siddha Drug Development, Arumbakkam, Chennai-106. 
 
4.2.1.1 Organoleptic characterization   -   (The results expressed in Table – 01) 
Colour 
The Seenthil Chooranam was taken into watch glasses and placed against white back 
ground in white tube light. It was observed for its colour by naked eye. 
Odour 
The Seenthil Chooranam was smelled individually. The time interval among two 
smelling was kept 2 minutes to nullify the effect of previous smelling. 
Taste 
 Small amount of Seenthil Chooranam was kept over the tip of the tongue  
 
4.2.1.2 Microscopic 
The drug sample passed through sieve 80 and used for microscopic studies. It 
was carried out as per the procedure. Microscopic slides were prepared either by 
soaking a pinch of fine powder in distilled water for 1hr. and staining with saffranin 
for 2-4 minutes or treating with solution of chloral hydrate for 1 hr and staining with 
phloroglucinol followed by addition of 1-2 drops of conc.HCl.  The mounting 
medium is glycerine 50%
39,40,41
. 
The images of pharmacognostical studies were shown in figures 2-4 
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4.2.2. PHYSICOCHEMICAL ANALYSIS 
 Physicochemical properties of Seenthil Chooranam was analyzed at Captain 
Srinivasamurti Reseach Institute for Ayurveda and Siddha Drug Development, Arumbakkam, 
Chennai-106.  
Physico-chemical studies of the plant drugs are necessary for standardization, as it helps 
in under-standing the significance of physical and chemical properties of the substance being 
analyzed in terms of their observed activities and especially for the determination of their 
purity and quality. The analysis include the determination of ash value, Loss on drying of the 
sample at 105ºC, pH value, Extractive value. These were carried out as per guidelines
42
. 
i. Determination of pH:  
Five grams of Seenthil Chooranam was weighed accurately and placed in clear 100 
ml beaker. Then 50 ml of distilled water was added to it and dissolved well. After 30 minutes 
it was then applied in to pH meter at standard buffer solution of 4.0, 7.0, and 9.2. Repeated 
the test four times and average was recorded. 
ii. Loss on drying of the sample at 105ºC 
4g of test drug was weighed in a previously weighed 100ml beaker and heated in an 
oven at 105ºC for 5hours. Cooled in a dessicator and weighed.  Repeated the procedure till 
constant weight was obtained.  The percentage loss in weight of the test drug was calculated 
by the following formula. 
Calculation: 
                                                                     Loss in weight of test drug 
Percentage of loss on drying at 105ºC   =   ---------------------------------------x 100 
                                                                     Weight of test drug taken 
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iii. Ash content  
a. Total ash content  
4g of test drug was weighed accurately in a previously ignited and tared silica dish.  
The material was evenly spread and ignited in a muffle furnace at 600⁰C until it became 
white indicating the absence of carbon.  The dish was cooled in a dessicator and weighed.   
As carbon free ash cannot be obtained in this manner, the dish was cooled and the residue 
moistened with sufficient quantity of water.  Dried on a water bath and then ignited in the 
electric furnace to get the constant weight. Cooled the dish in a dessicator and then weighed. 
The percentage of total ash of air-dried materials was calculated as per the formula given 
below.  
Calculation: 
                                   Weight of the ash   
Percentage of total ash   =   --------------------------------- x 100 
                                   Weight of test drug taken 
 
b. Acid-insoluble ash  
     The total ash of the test drug was found out as described above. To the dish containing the 
total ash was added 45 ml of 1: 5 hydrochloric acid in three portions of 13 ml each time.  
Boiled gently for 5 minutes and filtered. Collected the insoluble matter on an ashless filter 
paper (Whatman No.41) and washed with distilled water until the residue was free from acid.  
Transfer the filter paper containing the insoluble mater to the original dish.  Dried and ignited 
to the constant weight. Cooled the dish in a dessicator, and then weighed.  Calculation was 
made by given formula. 
             Calculation: 
                                     Weight of the acid-insoluble residue   
Percentage of acid-insoluble ash   =   -------------------------------------------- x 100 
                                                          Weight of test drug taken 
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iv. Extractive of the test drug 
a. Water-soluble extractive of the test drug 
       4 g of the test drug was weighed accurately in a glass stoppered flask. Added 100 ml of 
distilled water and shacked occasionally for 6 hours and then allowed to stand for 18 hours. 
Filtered rapidly taking care not to lose any solvent and pipetted out 25 ml of the filtrate in a 
preweighed 100 ml beaker and evaporated to dryness on a water bath. Kept in an air oven at 
105ºC for 6 hours.  Cooled in a dessicator and weighed.  Repeated the experiment twice, and 
taken the average value. The percentage of water soluble extractive was calculated by the 
formula given below. 
 
Calculation: 
                                                                         Weight of the extract      100 
   Percentage of water soluble extract   =   -------------------------------- x --------- x 100  
                                                                         Weight of sample taken   25 
 
b. Alcohol-soluble extractive of the sample   
       4 g of the sample was weighed accurately in a glass stoppered flask. Added 100 ml of 
distilled alcohol (approximately 95%) and shaken occasionally for 6 hours and then allowed 
to stand for 18 hours.  Filtered rapidly taking care not to lose any solvent and pipetted out 25 
ml of the filtrate in a preweighed 100 ml beaker and evaporated to dryness on a water bath.  
Kept in an air oven at 105ºC for 6 hours and cooled in a dessicator and weighed.  
Repeated the experiment twice, and taken the average value. The percentage of alcohol 
soluble extractive was calculated by the formula given below. 
Calculation: 
                                                                 Weight of the extract                  100 
 Percentage of alcohol soluble extract   =  ------------------------------- x ---------------  x 100  
                                                                  Weight of sample taken               25 
 
 
(The results were tabulated in Table – 02) 
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4.2.3 CHEMICAL ANALYSIS OF SEENTHIL CHOORANAM 
 The chemical analysis of SEENTHIL CHOORANAM was carried out in Bio chemistry 
Lab, NATIONAL INSTITUTE OF SIDDHA. 
Table : 1 
S.No EXPERIMENT OBSERVATION INFERENCE 
1.  Physical Appearance of extract Yellowish brown  
2. Test for Slicate 
a. A 500mg of the sample was shaken 
well with distilled water. 
 
Sparingly soluble 
 
 
 
Presence of Silicate 
 
 3. Action of Heat: 
   A 500mg of the sample was taken in 
a dry test tube and heated gently at 
first and then strong. 
 No White fumes 
evolved. 
No brown fumes 
evolved. 
 
Absence of 
Carbonate 
 Absence of Nitrate. 
 
 
 
4. Flame Test: 
  A 500mg of the sample was made 
into a paste with con. HCl in a watch 
glass and introduced into non-
luminous part of the Bunsen flame. 
 
 bluish green flame 
present 
 
 
Present  of copper 
 
 
5. Ash Test: 
A filter paper was soaked into a 
mixture of extract and dil. cobalt 
nitrate solution and introduced into the 
Bunsen flame and ignited. 
 
Appearance of yellow 
colour flame 
 
 
 
 
flame  
 
 
 
flame 
 
Absence of sodium 
 
 
 
Preparation of Extract: 
5gm of sample was taken in a 250ml clean beaker and added with 50ml of distilled 
water. Then it is boiled well for about 10 minutes. Then it is cooled and filtered in a 100ml 
volumetric flask and made up to 100ml with distilled water. This preparation is used for the 
qualitative analysis of acidic/basic radicals and biochemical constituents in it. 
31 
 
S.No EXPERIMENT OBSERVATION INFERENCE 
I. Test For Acid Radicals 
1. Test For Sulphate: 
2ml of the above prepared extract was 
taken in a test tube and 2ml of 4% dil. 
ammonium oxalate solution was added. 
Presence of 
Cloudy 
appearance 
 
Sulphate  
present  
2. Test For Chloride:  
 2ml of the above prepared extracts was 
added with 2ml of dil-HNO3 until the 
effervescence ceases off. Then 2 ml of 
silver nitrate solution was added. 
Presence of 
Cloudy 
appearance 
Chloride 
Present 
3. Test For Phosphate: 
 2ml of the extract was treated with 2ml of 
con.HNo3 and 2ml of 
dil.ammoniummolybdate solution.   
Absence of 
Yellow precipitate 
 
Phosphate 
absent 
4.  Test For Carbonate: 
    2ml of the extract was treated with 2ml 
dil. magnesium sulphate solution 
Absence of 
Cloudy 
appearance 
 Carbonate 
absent 
5. Test For Nitrate: 
1gm of the substance was heated with 
copper turning and concentrated H2SO4 
and viewed the test tube vertically down. 
Brown gas was 
not evolved 
Nitrate absent 
6. Test For Sulphide: 
1gm of the substance was treated with 2ml 
of con. HCL 
Rotten Egg 
Smelling gas was 
not evolved 
Sulphide absent 
7. Test For Fluoride & Oxalate: 
  2ml of extract was added with 2ml of dil. 
Acetic acid and 2ml dil.calcium chloride 
solution and heated. 
 
Absence of 
Cloudy 
appearance 
fluoride and 
oxalate were 
absent 
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8. Test For Nitrite: 
3drops of the extract was placed on a filter 
paper, on that-2 drops of dil.acetic acid and 
2 drops of dil.Benzidine solution were 
placed. 
Characteristic 
changes not 
appeared 
Nitrite absent 
II. Test For Basic Radicals 
1. Test For Lead: 
        2ml of the extract was added with 2ml 
of dil.potassium iodine solution. 
Yellow 
Precipitate was 
not obtained. 
Lead         
absent 
2. Test For Copper: 
One pinch (25mg) of substance was made 
into paste with con. HCl in a watch glass 
and introduced into the non-luminuous part 
of the flame. 
Blue colour 
precipitate was 
not formed. 
 
Copper                       
absent 
 
3. Test For Aluminium: 
  In the 2ml of extract dil.sodium 
hydroxide was added in 5 drops to excess. 
Yellow colour 
was not formed 
Aluminium 
absent 
4. Test For Iron: 
a. To the 2ml of extract add 2ml of 
dil.ammonium solution 
b. To the 2ml of extract 2ml  thiocyanate 
solution and 2ml  of con HNo3 is added 
Presence of brown 
precipitate 
Mild red 
colourformed 
 
Iron     present 
 
5. Test For Zinc:  
 In 2ml of the extract dil.sodium hydroxide 
solution was added in 5 drops to excess 
and dil.ammonium chloride was added.  
 
White precipitate 
was not formed 
Zinc          
absent 
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6. Test For Calcium:  
2ml of the extract was added with 2ml of 
4% dil.ammonium oxalate solution  
Cloudy 
appearance was  
formed 
Calcium  
present 
7. Test For Magnesium:  
In 2ml of extract dil.sodium hydroxide 
solution was added in drops toexcess. 
 
white precipitate 
not formed 
 
Magnesium 
absent 
8. Test For Ammonium: 
 In 2ml of extract 1 ml ofNessler’s reagent 
and excess of dil.sodium hydroxide 
solution were added. 
 
Brown colour not 
formed 
 
Ammonium 
absent 
9. Test For Potassium: 
A pinch (25mg) of substance was treated  
with 2ml of dil.sodium nitrite solution and 
then treated with 2ml of dil.cobalt nitrate 
in 30% dil.glacial acetic acid. 
 
Yellowish 
precipitate was 
formed 
 
Potassium 
present 
10. Test For Sodium: 
    2 pinches (50mg) of the substance was 
made into paste by using HCl and 
introduced into the blue flame of Bunsen 
burner. 
 
Yellow colour 
flame was 
appeared 
 
Sodium      
present 
 
11. Test For Mercury:  
 2ml of the extract was treated with 2ml of 
dil.sodium hydroxide solution.  
 
Yellow precipitate 
not formed 
 
Mercury   
 Absent 
12. Test For Arsenic:  
   2ml of the extract was treated with 2ml 
of dil.sodium hydroxide solution. 
Brownish red 
precipitate not 
formed 
 
Arsenic     
absent 
 
34 
 
III. Other constituents 
1.  Test For Starch : 
  2ml of extract was treated with weak 
dil.iodine solution  
Blue colour 
developed 
Starch             
present 
2.  Test For Reducing Sugar: 
    5ml of Benedict's qualitative solution 
was taken in a test tube and allowed to boil 
for 2 minutes and added 8 to 10 drops of 
the extract and again boil it for 2 minutes.  
The was no 
specific change in 
colour 
Reducing sugar 
absent 
3.  Test For The Alkaloids: 
a) 2ml  of the extract is treated with 
2ml of dil.potassiumlodide 
solution.     
b) 2ml of the extract is treated with 
2ml of dil.picric acid. 
Reddish brown 
precipitation was 
formed 
Yellow 
precipitation was 
formed 
Alkaloid 
Present 
4.  
 
Test For Tannic Acid:  
2ml of extract was treated with 2ml of 
dil.ferric chloride solution 
Black precipitate 
not formed 
Tannic acid 
absent 
5.  Test For Unsaturated Compound: 
In the 2ml of extract 2ml of dil.Potassium 
permanganate solution was added.  
Potassium 
permanganate was 
decolourised 
unsaturated 
compounds 
present 
6.  Test For Amino Acid: 
2 drops of the extract was placed on a filter 
paper and dried well, then 20ml of Biurette 
reagent was added in it. 
Violet colour not  
developed 
Amino acids 
absent 
7. Test For phenols: 
2ml of the extract was treated with 2 ml of 
dil.ferric chloride solution.  
No specific colour 
formation 
Phenols    
absent 
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4.2.4 TLC/HPTLC finger print analysis 
 4g of the sample was soaked in 40ml of alcohol, boiled, filtered, concentrated and 
made up 10 ml in a 10ml standard flask. 5µl, 10Fµl of the solution was applied on Merck 
Aluminium plate pre-coated with Silica gel 60 F 254 of 0.2 mm thickness. The plate was 
developed in Toluene: Ethyl acetate (8:2). The plate was dried and visualized in UV 254 and 
UV 366 nm and photographs were taken. Before derivitization of the plate it was scanned at 
UV 254 nm and finger print was taken before dipping in Vanillin-Sulphuric acid reagent
43
, 
44
. 
 
4.2.5 ESTIMATION OF HEAVY METALS (AAS) 
Instrument details:  
Thermo FisherM Series, 650902 V1.27 model Atomic Absorption Spectrometer 
(AAS) was used for the analysis. The operating parameters
45, 46
 
Lead and Cadmium:  
Instrument technique  : Flame technique 
Wavelength (Lead)  : 217 nm 
Wavelength (Cadmium) : 228.8 nm 
Slit width    :  0. 5 mm 
Lamp current (Pb)   :  4.0 mA 
Lamp current (Cd)   :  3.0 mA  
Carrier gas and flow rate : Air and Acetylene, 1.1 L/min 
Flow rate   : 2 ml/min 
 
Mercury:  
Instrument technique  : Cold vapour technique 
Wavelength    : 253.7 nm 
Slit width    : 0. 5 mm 
 Lamp current    : 3.0 mA,  
Carrier gas and flow rate : Argon, 1.1 L/min 
Flow rate   : 5ml/min 
The Hallow cathode lamp for Pb, Cd and Hg analysis were used as light source to provide 
specific wavelength for the elements to be determined. 
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4.2.6 DETERMINATION OF MICROBIAL LOAD  
Microbial analysis was carried for determination of microbial contamination as per 
procedures of Quality Control Methods for Medicinal plant Materials, WHO Geneva 1998 
Guideline. The test included total bacterial count, total fungal count,and identification of 
specified organisms such as Enterobacteriaceae, Escherichia coli, Salmonella spp, 
Staphylococcus aureus and Pseudomonas aeroginosa
42i
.( The results expressed in Table – 03) 
 
4.2.6 ELEMENTAL ANALYSIS 
Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES) 
 The ICP- OES is a trace-level elemental analysis technique that uses the emission 
spectra of a sample to identify and quantify the elements present. The Experimental 
Procedure was done at SAIF, IIT Madras, Chennai-36. 
Introduction 
The elemental composition of a sample is often an important part of the information 
needed to assess its properties. Hence there is a need for sensitive scientific instrumentation 
like ICP – OES which plays a pivotal role in the determination of these elements ICP – OES 
is widely employed for the estimation of metals and metalloids at trace, minor and major 
concentrations. 
Principal 
In this technique, the high temperature plasma source atomizes the sample and excites 
the atoms resulting in emission of photons. The atoms of each element in the sample emit 
specific wavelength of light. The emission spectrum from the plasma is dispersed by an 
optical spectrometer, so that intensities of the individual wavelength can be measured. The 
number of photons emitted is directly proportional to the concentration of the element. The 
photon may be detected either sequentially or simultaneously. Quantitative analysis is 
achieved by measuring the intensity of these specific wavelengths and after performing the 
calibration using known standards 
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Sample preparation – Microwave Digestion 
Weigh 0.25g of Seenthil chooranam and transfer into a liner provided with the 
instrument and add 9ml of Nitric acid or Sulphuric acid slowly such that no piece of sample 
sticks on the slides. Mix gently and allow reacting sometimes, placing the liner in the vessel 
jacket and closing the screw cap hand tight and sealing it and placed in the rotor fixed in 
microwave. Set temperature to 180°C   for 10 minutes, then allowed to cool down to a vessel 
interior temperature below 60°C and a vessel surface temperature (IR) below 50°C before 
removing the rotor. 
The drug Seenthil Chooranam underwent microwave digestion for sample 
preparation.  
The digested sample was made up to 100ml with Millipore water if visible insoluble 
particles exist, solution could be filtered through whatmann filter paper and transfer the 
digested solution into plastic containers and label them properly. 
4.2.8 ANALYSIS OF PARTICAL SIZE  
Scanning Electron microscopy (SEM) 
 The partical size of the Seenthil Chooranam was determined using Scanning electron 
microscopy (SEM). The Experimental Procedure was done at SAIF, IIT Madras, Chennai-36. 
SEM: 
   The SEM analysis is carried out by using FEI-Quanta FEG 200-HighResolution Instrument. 
Resolution   :   1.2 nm gold particle separation on a carbon substrate 
     Magnification   :   From a min of 12 X to greater than 1,00,000 X. 
     Application    :   To evaluate grain size, particle size distributions, material       
        Homogeneity and inter metallic distribution 
Calculation of the particle size: 
The horizontal line in the right corner of the micrograph corresponds to micron in 
length would be given. A comparison could be made between the length of the particles 
visible in the micrograph with this line and the length of the particle was calculated. 
  
Toxicological Studies 
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5. TOXICITY STUDIES 
5.1. ACUTE ORAL TOXICITY-EXPERIMENT PROCEDURE 
 
Acute toxicity studies were carried out according to the OECD (Organization of 
Economic Co-operation and Development) guidelines 423. Healthy female rats, weighing 
150–200 g, were selected and oral administration of the single doses of Seenthil Chooranam 
were done aseptically by suspending ghee (melted and used as vehicle)
47,48
. 
Administration of doses:  
Seenthil Chooranam in Ghee was administered as a single oral dose by gavage using a 
feeding needle. Animals were fasted prior to dosing. Following the period of fasting, the 
animals were weighed and then the test substance was administered. After the substance has 
been administered, food was withheld for a further 3-4 hours. The principle of laboratory 
animal care was followed. The principles of laboratory animal care were followed and the 
Institutional Animal Ethical Committee approved Number: KKCP/ 2015/ 034 
Observations were made and recorded systematically and continuously observed as 
per the guideline after substance administration. The substance is administered orally to a 
group of experimental animals at one of the defined doses. The substance is tested using a 
stepwise procedure, each step using three animals of a single sex. Absence or presence of 
compound-related mortality of the animals dosed at one step will determine the next step, i.e.; 
− no further testing is needed − dosing of three additional animals with be the same dose − 
dosing of three additional animals at the next higher or the next lower dose level. The method 
will enable a judgment with respect to classifying the test substance to one of a series of 
toxicity classes.      
 The general behaviors of the rats were continuously monitored for 1 h after dosing, 
periodically during the first 24 h (with special attention given during the first 4 hours and 
then daily thereafter, for a total of 14 days. Changes in the normal psychomotor activity and 
external morphology and their body weights were monitored periodically before dosing and 
the time at which signs of toxicity or mortality were recorded. 
 The visual observations included skin changes, mobility, aggressively, sensitivity to 
sound and pain, as well as respiratory movements. They were deprived of food, but not water 
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12 h prior to the administration of the test substance. Finally, the number of survivors was 
noted after 24 h and these animals were then maintained for a further 14 days and 
observations made daily. The toxicological effect was assessed on the basis of mortality.  
Number of animals and dose levels:  
 Since this test drug has been under practice for long time and likely to be non-toxic, a 
limit test at one dose level of 2000 mg/kg body weight will be carried out with 3 animals The 
available information suggests that mortality is likely at the highest starting dose level 
2000mg/kg body weight, so the trial or limit test was conducted. The time interval between 
treatment groups is determined by the onset, duration, and severity of toxic signs.  
 
Limit test 
 The limit test at one dose level of 2000 mg/kg body weight was carried out with three 
animals per step. The test substance-related mortality was not produced in animals, so further 
testing at the next lower level need not be carried out.  
 
Observations:  
 Animals were observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the first 4 
hours, and daily thereafter, for a total of 14 days, except where they need to be removed from 
the study and humanely killed for animal welfare reasons or are found dead. It should be 
determined by the toxic reactions, time of onset and length of recovery period, and may thus 
be extended when considered necessary. The times at which signs of toxicity appear and 
disappear are important, especially if there is a tendency for toxic signs to be delayed. All 
observations are systematically recorded with individual records being maintained for each 
animal. Observations include changes in skin and fur, eyes and mucous membranes, and also 
respiratory, circulatory, autonomic and central nervous systems, and somato motor activity 
and behavior pattern. Attention was directed to observations of tremors, convulsions, 
salivation, diarrhea, lethargy, sleep and coma. The principles and criteria summarized in the 
Humane Endpoints Guidance Document taken into consideration. Animals found in a 
moribund condition and animals showing severe pain or enduring signs of severe distress was 
humanely killed. When animals are killed for humane reasons or found dead, the time of 
death should was recorded. 
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5.2. REPEATED DOSE 28-DAYS ORAL TOXICITY STUDY OF  
SEENTHIL CHOORANAM (OECD – 407 GUIDELINES) 
Sub-acute toxicity studies were carried out according to OECD 407 and rats were 
divided into 3 groups of 10 animals (5 male and 5 female). Group I served as control (fixed 
volume of Ghee) and Group-II and III were treated with Seenthil Chooranam at the dose of 
900 & 1800 mg/kg/day for 28 days. The toxic symptoms such as signs of toxicity, mortality 
and body weight changes were monitored. Rats were anesthetized with ether at the end of the 
treatment period. All rats were sacrificed after the blood collection
49
. 
Test Substance : Seenthil Chooranam (Ghee as vehicle) 
Animal Source  : Animal house of King Institute of Preventive Medicine 
Animals : Male and Female Wistar Albino Rats  
Age  : More than 8 weeks 
Acclimatization : Seven days prior to dosing. 
Veterinary examination : Prior to and at the end of the acclimatization period. 
Identification of animals : By cage number, animal number and individual marking on 
fur. 
Diet : Pelleted feed supplied by Sai meera foods Pvt Ltd, Bangalore 
Water  : Aqua guard portable water in polypropylene bottles ad libitum. 
Housing & Environment : The animals were housed in Polypropylene cages provided 
with bedding of husk. 
Housing temperature : Between 20 & 24°C,  
Relative humidity : Between 30% and 70%, 
Dark and light cycle  : Each of 12 hours. 
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Justification for Dose Selection: 
 The results of acute toxicity studies in rats indicated that Seenthil Chooranam was 
non toxic and no behavioral changes was observed up to the dose level of 2000mg/kg body 
weight in acute treatment. In the literature, therapeutic dosage for Seenthil Chooranam in 
human is mentioned as 2gm per day. The oral route was selected for use because oral route is 
considered to be a proposed therapeutic route.  As per OECD guideline dose level of at least 
1000mg/kg produces no observable toxic effects the limit test applies based on that two dose 
levels were selected for the study. They were, mid dose (5X) and high dose (10X). X was 
calculated by multiplying the therapeutic dose (2000 mg) and the body surface area of the rat 
(0.018). i.e , 5X dose was 180mg/animal,10X dose was 360 mg/animal. 
Preparation and administration of dose:  
Seenthil Chooranam was suspended in melted ghee. The suspension was administered 
to animals at the dose levels of 900 and 1800 mg/kg. The test substance suspensions were 
freshly prepared every day for 28 days. The control animals were administered vehicle 
(10ml/kg) only. Administration was by oral (gavage), once daily for 28 consecutive days. 
 
METHODOLOGY 
Randomization, Numbering and Grouping of Animals: 
 Ten Rats (Five Male and Five Female) in each group randomly divided into three 
groups for dosing up to 28 days. Animal’s acclimatization period of 7 days to laboratory 
conditions prior to the initiation of treatment. The principles of laboratory animal care were 
followed and the Institutional Animal Ethical Committee approved Number KKCP/ 2015/ 
034 each animal was fur marked with picric acid. The females were nulliporous and non-
pregnant. 
OBSERVATIONS: 
Experimental animals were kept under observation throughout the course of study for 
the following: 
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Body Weight: 
Weight of each rat was recorded on day 0 and at 7 days intervals throughout the course of 
study and at termination to calculate relative organ weights. From the data, group mean body 
weights and percent body weight gain were calculated. (Table-10) 
Food and water Consumption:  
The quantity of food consumed by groups consisting of six animals of for different 
doses was recorded at weekly interval. Food consumed per animal was calculated for control 
and the treated dose groups. (Table-11 and 12) 
Clinical signs:  
All animals were observed daily for clinical signs. The time of onset, intensity and 
duration of these symptoms, if any, were recorded. 
Mortality:  
All animals were observed twice daily for mortality during entire course of study. 
TERMINAL STUDIES: 
Laboratory Investigations:  
Following laboratory investigations were carried out on day 29 in animals’ fasted 
over-night. On 29th day, the animals were fasted for approximately 18 h, then slightly 
anesthetized with ether and blood samples were collected from the retro-orbital plexus into 
two tubes: one with EDTA for immediate analysis of haematological parameters, the other 
without any anticoagulant and was centrifuged at 4000 rpm at 4 °C for 10 minutes to obtain 
the serum. Serum was stored at 20 °C until analyzed for biochemical parameters. 
Haematological Investigations:  
Blood samples of control and experimental rats was analyzed for hemoglobin content, 
total red blood corpuscles (RBC), white blood corpuscles (WBC) count, Mean corpuscular 
volume (MCV) and packed cell volume (PCV). From the estimated values of RBC count 
(millions/mm3) and PCV (volumes percent), mean corpuscular volume (MCV) was 
calculated.  
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Biochemical Investigations:  
Serum and Urine was used for the estimation of biochemical parameters. Samples of 
control and experimental rats were analyzed for protein, bilirubin, urea, uric acid, creatinine, 
triglyceride, cholesterol and glucose levels was carried using standard methods. Activities of 
Serum glutamate oxaloacetate transaminase/ Aspartate aminotransferase (SGOT/AST), 
Serum glutamate pyruvate transaminase/ Alanine amino transferase (SGPT/ALT) and 
alkaline phosphatase were estimated as per the colorimetric procedure.  
Necropsy: 
All the animals were sacrificed on day 29. Necropsy of all animals was carried out 
and the weights of the organs including liver, kidneys, brain, heart, and lungs were recorded. 
The relative organ weight of each animal was then calculated as follows; 
     Absolute organ weight (g) 
Relative organ weight = ____________________________________________ ×100 
    Body weight of rats on sacrifice day (g) 
Histopathology: 
Histopathological investigation of the vital organs was done. The organ pieces (3-
5µm thick) were preserved and were fixed in 10% formalin for 24 h and washed in running 
water for 24 h. Samples were dehydrated in an auto technicon and then cleared in benzene to 
remove absolute alcohol.  Embedding was done by passing the cleared samples through three 
cups containing melted paraffin at 50°C and then in a cubical block of paraffin made by the 
“L” moulds. It was followed by microtome and the slides were stained with Haematoxylin-
eosin.   
The organs included brain, heart, kidneys, liver and lungs of the animals were 
preserved they were subjected to histopathological examination. 
Statistical analysis:  
Findings such as clinical signs of intoxication, body weight changes, food 
consumption, and hematology and blood chemistry were subjected to One-way Anova.  
Followed by dunnet’t’ test using a computer software programme. (Graph Pad Prism5). 
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5.3. REPEATED DOSE 90-DAYS ORAL TOXICITY STUDY OF 
SEENTHIL CHOORANAM (OECD GUIDELINE - 408)
50
 
Test Substance  :  SEENTHIL CHOORANAM 
Animal Source  :  King Institute ,Guindy, Chennai.   
Animals   :  Wistar Albino Rats (Male -12, and Female-12) 
Age    :  6-8 weeks 
Body Weight    :  150-200gm. 
Acclimatization  :  Seven days prior to dosing. 
Veterinary examination :  Prior and at the end of the acclimatization period. 
Identification of animals :   By cage number, animal number   and    individual    
   marking by using Picric acid. 
 
Diet    :  Pellet feed supplied by Sai meera foods Pvt Ltd,       
      Bangalore 
Water    :  Aqua guard portable water in polypropylene bottles. 
Housing & Environment :  The animals were housed in Polypropylene cages  
      provided with bedding of husk. 
Housing temperature :  Between 22ºC +3ºC.  
Relative humidity  :  Between 30% and 70%, 
Air changes    :  10 to 15 per hour  
Dark and light cycle   :  12:12 hours. 
Duration of the study :  90 Days. 
 
METHODOLOGY 
Randomization, Numbering and Grouping of Animals: 
24 Wistar Albino Rats (12M + 12F) were selected and divided into 4 groups. Each 
group consists of 6 animals (Male -3, and Female-3). Group I treated as a control and other 
three groupswere treated with test drug (low, mid, high) for 90 days. Animals were allowed 
acclimatization period of 7 days to laboratory conditions prior to the initiation of treatment. 
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The principles of laboratory animal care were followed and the Institutional Animal Ethical 
Committee approved Number: NIS/ IAEC-I/ 2016/ 08. Each animal was marked with picric 
acid. The females were nulliparous and non-pregnant. 
 
Justification for Dose Selection: 
         As per OECD guideline three dose levels were selected for the study. They were low 
dose (X), mid dose dose (5X), high dose (10X). X is calculated by multiplying the therapeutic 
dose (2000mg) and the body surface area of the rat (0.018). i.e X dose is 36 mg/animal, 5X 
dose is 180 mg/animal,10X dose is 360 mg/animal. 
Preparation and Administration of Dose: 
SEENTHIL CHOORANAM was suspended in melted Ghee with distilled water to obtain 
concentrations of 200mg/ml. It was administered to animals at the dose levels of X, 5X, 10X. 
The test substance suspensions were freshly prepared every two days once for 90 days. The 
control animals were administered vehicle only. The drug was administered orally by using 
oral gavage once daily for 90 consecutive days. 
OBSERVATIONS: 
Experimental animals were kept under observation throughout the course of study for 
the following: 
 
 Body Weight: 
 Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study. 
 Clinical signs:  
 All animals were observed daily for clinical signs. The time of onset, intensity 
and duration of these symptoms, if any, were recorded. 
 
 Mortality: 
 All animals were observed twice daily for mortality during entire course of 
study. 
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 Laboratory Investigations: 
Following laboratory investigations were carried out on day 91 in 
animals’fasted over-night. Blood samples were collected from orbital sinus using 
sodium heparin (200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for 
Haematology as anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 
minutes. 
 
 Haematological Investigations: 
Haematological parameters were determined using Haematology analyzer.  
 
 Biochemical Investigations:  
Biochemical parameters were determined using auto-analyzer. 
 
 Histopathology:   
All the vital organs obtained were immersed in 10% formalin for 24  h-48h 
for histopathological examination. After standard processing, the cut tissue was 
embedded in paraffin (Leica TP1020 tissue processor) and cut into 5  μm thick 
sections in a rotary microtome (Leica RM2255 - Fully Automated Rotary 
Microtome). The sections were stained with haematoxylin-eosin (Merck). 
Histological measurement and photographs were taken with Olympus CX31, 
Trinocular Biological Microscope (magnification 10x& 40 x). 
 
 Statistical analysis:  
Findings such as clinical signs of intoxication, body weight changes, food 
consumption, haematology and blood chemistry were subjected to One-way ANOVA 
followed by dunnet’t’test using a computer software programme (Graph Pad Prism5). 
  
  
Pharmacological Studies 
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6.  PHARMACOLOGICAL STUDIES 
6.1. ANTIDIABETIC ACTIVITY OF SEENTHIL CHOORANAM 
Aim: 
  To study the Antidiabetic activity of Seenthil Chooranam in Wistar albino rats by 
Steptozotocin-induced method. 
 
Materials and methods: 
Test Substance  :  Seenthil Chooranam 
Animal Source  :  King institute of preventive medicine, Guindy.  
Animals   :  Wistar Albino Rats (Male-15 + Female-15) 
Age    :  6-8 weeks 
Body Weight    : 150-200gm. 
Acclimatization  :  14 days prior to dosing.  
Veterinary examination :  Prior and at the end of the acclimatization period. 
Identification of animals :  Bycage number, animal number   and    individual    
             
   marking by using    Picric acid. 
Diet    :  Pellet feed 
Water    :  Aqua guard portable water in polypropylene bottles. 
Housing & Environment :  The animals were housed in Polypropylene cages  
      provided with bedding of husk. 
Housing temperature :  24-28°C 
Relative humidity  : Between 30% and 70%, 
Air changes    :  10 to 15 per hour  
Dark and light cycle   :  12:12 hours. 
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Selection of animals: 
Healthy Wistar albino rats (150- 200g) of  both sexes were used for this study with the 
approval of the Institutional Animal Ethics Committee and obtained from the animal 
laboratory. IAEC approved no: KKCP/2015/034 
The animals kept in plastic cages and maintained at 24-28°C. All the rats were housed 
individually with free access to food, water and libitum. They were feed with standard diet 
and kept in well ventilated animal house they also maintained with alternative dark-light 
cycle of 12hrs throughout the studies. Rats were allowed an acclimatization period of 14 days 
before actual experiments. The rats were closely observed for any infection and if they show 
signs of infection they were excluded from the study. The animal experiment was performed 
with accordance legislation on welfare. 
 
Experimental procedure: 
Healthy Adult wistar rats weighing (150-200g) were used in the experiment. The rats 
were divided in to five groups which consisting six animals in each group. Group I formed as 
control group received the vehicle as ghee. Group II were treated as diabetic control received 
Streptozocin 40mg/kg, group III were treated with Glabenclamide 5mg/kg, group IV and 
group V formed the drug treated groups and received the Seenthil Chooranam 200,400 mg/kg 
respectively. All the groups were treated with the drugs for 28 days.  
 
Induction of diabetes: 
Diabetes was induced in overnight fasted experimental wistar rats by a single 
intraperitoneal injection of STZ (40 mg/kg) dissolved in freshly prepared citrate buffer (0.1 
M, pH 4.5)
51
. STZ injected animals were allowed to drink 20% glucose solution overnight to 
overcome the initial drug-induced hypoglycemic mortality. After 96 h, plasma glucose was 
determined and those rats with fasting blood glucose greater than 250 mg/dl were used in the 
present study. 
 
 
49 
 
Drug administration: 
 
The initial and ﬁnal body weight of the rats in each group was recorded at the end of 
the experimental period, the animals were fasted overnight, anesthetized using ketamine 
hydrochloride (24 mg/kg intramuscular injection), and sacriﬁced by cervical decapitation. 
Blood samples for sugar estimation, Bio chemical parameter and Lipid profile were collected 
from the rats through retro orbital venous plexus and collected in dry test tubes were allowed 
to coagulate at ambient temperature for 30 min centrifugation at 2000 rpm for 10 min
52
. 
 
All results were reported as mean ± SEM. They were further analyzed using one way 
analysis of varients (ANOVA) followed by Tukey’s multiple comparison test. Except Body 
weight, food and water intake were followed by Dunnet’s test 
 
 
 
 
 
 
 
 
 
Groups Treatment 
Group I Normal Control 
Group II Diabetic control- STZ (40 mg/kg b.w) 
Group III STZ + glibenclamide (5 mg/kg) for 28 days 
Group IV STZ + Seenthil Chooranam 200mg/kg for 28 days 
Group V STZ + Seenthil Chooranam 400mg/kg for 28 days 
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6.2. HEPATOPROTECTIVE ACTIVITY OF SEENTHIL CHOORANAM 
 
Aim: 
  To study the Hepato- protective study of Seenthil Chooranam in Wistar albino rats by 
CCl4 induced hepatotoxicity method. 
 
Materials and methods: 
Test Substance  :  Seenthil Chooranam 
Animal Source  :  King institute of preventive medicine, Guindy.  
Animals   :  Wistar Albino Rats (Male -30) 
Age    :  6-8 weeks 
Body Weight    : 150-200gm. 
Acclimatization  :  14 days prior to dosing. 
Veterinary examination :  Prior and at the end of the acclimatization period. 
Identification of animals :  Bycage number, animal number   and    individual    
           
   marking by  using    Picric acid. 
 
Diet    :  Pellet feed 
Water    :  Aqua guard portable water in polypropylene bottles. 
Housing & Environment :  The animals were housed in Polypropylene cages  
     provided with bedding of husk. 
Housing temperature :  24-28°C 
Relative humidity  : Between 30% and 70%, 
Air changes    :  10 to 15 per hour  
Dark and light cycle   :  12:12 hours. 
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Selection of animals: 
 
Healthy male Wistar albino rats (150- 200g) were used for this study with the approval 
of the Institutional Animal Ethics Committee and obtained from the animal laboratory. IAEC 
approved no: KKCP/2015/034 
The animals kept in plastic cages and maintained at 24-28°C. All the rats were housed 
individually with free access to food, water and libitum. They were feed with standard diet 
and kept in well ventilated animal house they also maintained with alternative dark-light 
cycle of 12hrs throughout the studies. Rats were allowed an acclimatization period of 14 days 
before actual experiments. The rats were closely observed for any infection and if they show 
signs of infection they were excluded from the study. The animal experiment was performed 
with accordance legislation on welfare. 
Experimental design: 
The wistar rats were randomized into 5 groups comprising 6 animals in each group 
weighing between 150-200g. Rats in Group I received 10 ml/kg body weight of ghee orally 
once daily for 9 days. Groups III-IV rats were pre-treated  with  the  extract  of  Seenthil 
Chooranam 200 and 400 mg/kg for 7 days  once  daily  by  gastric  intubation.  Hepatic 
damage  was  induced  in  Groups  II  -  V  rats  as described by
53,54 
(Saraf and Dixit, 1991 
and  Mohideen et al., 2003)  administration of CCl4 intra peritoneally at the dose of 1.25 
ml/kg CCl4 in olive oil (at the ratio  of  1:1),  30  min  post-dose  of  Seenthil Chooranam on 
days  8  and  9  as  described  by (Oyagbemi  and  Odetola  2010)
55
.  Group V were fed with 
standard drug Silymarin 25mg/kg; p.o daily for seven days. The animals were fasted 
overnight and sacrificed on day 10 by cervical dislocation after collection of blood samples. 
 
Blood Sample Collection and Analysis  
Blood  samples  for  haematological  analysis were  collected  from  all  the  rats  
through  the  retro-orbital  venous  plexus  under  ether-induced anaesthesia, into heparinized 
tubes while the sample for  serum  biochemistry  was  collected  into  plain tubes.  From the 
blood samples collected, packed cell volume (PCV) was determined by micro haematocrit 
method,  haemoglobin  concentration  (Hb)  by cyanmethaemoglobin  method  while  the  red  
blood cells  (RBC)  and  white  blood  cells  (WBC)  were counted  using  haemocytometer.  
Mean  corpuscular volume  (MCV),  mean  corpuscular  haemoglobin (MCH)  and  mean  
corpuscular  haemoglobin concentration  (MCHC)  were  calculated  from  the values of 
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PCV, Hb and RBC count as described by Jain,  (1986)
56
. Erythrocyte  osmotic  fragility  was  
determined according  to  the  method  described  by  Oyewale, (1992)
57
  by  diluting  0.02ml  
of  blood  in  test  tubes containing 0 – 0.9% NaCl in phosphate buffer at pH of 7.4. The tubes 
were gently mixed and incubated at room  temperature  (29ºC)  for  30  minutes,  then 
centrifuged  at  3500rev/min  for  10  minutes.  The supernatant  were  decanted  and  the  
optical  density determined  at  540nm  using  SM22PC Spectrophotometer  (Surgienfield  
Instruments, England). Haemolysis in each tube was expressed as a percentage, taking the 
tube with the highest haemolysis  (i.e.  Distilled water with 0.0%  NaCl)  as 100%   
Serum Biochemistry  
 Whole blood was separated with high speed macro-centrifuge  at  3,500  rpm for  10  
minutes  and serum  was  separated  by  Pasteur  pipette  for  analysis of  the  following  
biochemical  assays;  Alkaline phosphatase (ALP) as described by Tietz and Shuey (1986)
58
,  
aspartate  aminotransferase  (AST), (Bergmeyer  et  al.,  1985)
59
,  alanine  aminotransferase 
(ALT) (Klauke et al., 1983)
60
 albumin (Varely, 1994)
61
 and total protein (Keller, 1984)
62
. 
All results were reported as mean ± SEM. They were further analyzed using one way 
analysis of varients (ANOVA) followed by Tukey’s multiple comparison test. 
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6.3. ANTI-INFLAMMATORY ACTIVITY OF SEENTHIL CHOORANAM 
 
Aim: 
  To study the Anti-inflammatory of Seenthil Chooranam in Wistar albino rats by 
Carrageenan-induced rat paw edema. 
 
Materials and methods: 
Test Substance  :  Seenthil Chooranam 
Animal Source  :  King institute of preventive medicine, Guindy.  
Animals   :  Wistar Albino Rats (Male -12, female -12) 
Age    :  6-8 weeks 
Body Weight    : 140-160gm. 
Acclimatization  :  14 days prior to dosing. 
Veterinary examination :  Prior and at the end of the acclimatization period. 
Identification of animals      :  Bycage number, animal number   and    individual    
          marking by  using    Picric acid. 
 
Diet    :  Pellet feed 
Water    :  Aqua guard portable water in polypropylene bottles. 
Housing & Environment :  The animals were housed in Polypropylene cages  
      provided with bedding of husk. 
Housing temperature :  24-28°C 
Relative humidity  : between 30% and 70%, 
Air changes    :  10 to 15 per hour  
Dark and light cycle   :  12:12 hours. 
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Selection of animals: 
Healthy Wistar albino rats (140- 160g) of  both sexes were used for this study with the 
approval of the Institutional Animal Ethics Committee and obtained from the animal 
laboratory. IAEC approved no: KKCP/2015/034 
The animals kept in plastic cages and maintained at 24-28°C. All the rats were housed 
individually with free access to food, water and libitum. They were feed with standard diet 
and kept in well ventilated animal house they also maintained with alternative dark-light 
cycle of 12hrs throughout the studies. Rats were allowed an acclimatization period of 14 days 
before actual experiments. The rats were closely observed for any infection and if they show 
signs of infection they were excluded from the study. The animal experiment was performed 
with accordance legislation on welfare. 
Experimental protocol 
Both sex of Adult wistar Albino rats weighing (140-160g) were used in this study. 
Rats were divided in to 4 groups, consisting six animals for each group. Group I were treated 
with ghee as a Vehicle, Group II treated with Seenthil Chooranam 200mg/kg, Group III 
treated with Seenthil Chooranam 400mg/kg and Group IV  treated with standard drug 
Indomethacin 10mg/kg. 
Acute inflammation was induced by carrageenan 30min after the drug treatment. 
Carrageenan was administrated by sub-planter injection of 0.1 ml freshly prepared 1% 
suspension in right hind paw in rats
63
.The paw volume was measured initially and then at 1, 
2, 3and 4 h after the carrageenan injection by using plethysmographic method
64
. 
All the results were reported as mean + SEM. They were further analyzed using Two 
way analysis of varients (ANOVA) followed by Tukey’s multiple comparison test 
 
 
  
Results 
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7.RESULTS OF SEENTHIL CHOORANAM 
 
Many studies have been carried out to bring the efficacy and potency of the drug Seenthil 
Chooranam. This study includes literary collections, organoleptic character, physicochemical 
and phytochemical analysis, Toxicityological study and pharmacological study. The drug 
Seenthil Chooranam  has been selected  from the text “Agathiyar Paripuranam 400”. 
 
 Botanical aspect explains the active principle and medicinal uses of the plants. 
 Gunapadam review brings the effectiveness of the drug in the management of 
Diabetes Mellitus 
 The pharmacological review explains about the  Evaluation Of Anti Diabetic, 
Hepatoprotective and Anti-Inflammatory Activities. 
 
 
STANDARDIZATION OF THE TEST DRUG 
 
Traditional remedies is advantageous, it does suffer some limitations. The main 
limitation is the lack of standardisation of raw materials, of processing methods and of the 
final products, dosage formulation, and the non- existence of criteria for quality control. 
Standardization of the drug is more essential to derive the efficacy, potency of the drug by 
analysing it through various studies. Following tables and charts are the results of 
physicochemical and chemical analysis. Physical characterization and estimation of basic and 
acidic radicals have been done and tabulated. Toxicityological results of the drug and 
pharmacological activity of the drug were derived. Its result has been tabulated below.  
 
7.1 ORGANOLEPTIC CHARACTER 
Table: 1. Organoleptic characters of Seenthil Chooranam 
      
      Colour         Yellowish Brown 
      Odour        Aromatic with rotten 
      Taste        Bitter 
      Texture       Fine powder 
      Particle size      Completely pass through sieve no 80 
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7.2 Pharmacognostical study 
 
Powder Microscopy of Seenthil Chooranam 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Figure no - 02 
 
 
 
 
 
 
 
 
Starch grains and prismatic 
crystals of calcium oxalate. 
Sclereid 
Fragment of parenchyma cells. 
Stone cells embedded with 
prismatic crystals of calcium 
oxalate under polarizer light. 
Prismatic crystals of calcium 
oxalate under polarizer light. 
Fragment of parenchyma and 
annular vessel cells 
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Figure no - 03 
  
 
 
 
 
 
 
 
 
 
Fragment of fibre. Fragment of reticulate vessel 
Fragment of spiral vessel. 
Seta. 
 
Fragment of cork cells in surface 
view. 
 
Pollen grain. 
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Figure no - 04 
 
 
 
 
 
 
 
 
 
 
Fragment of bordered pitted 
vessel and stone cells. 
 
Striking trichome 
Striking trichome 
Fragment of anomocytic and 
anisocytic stomata with 
subsidiary cells 
Fragment of reticulate and spiral 
vessel 
Fragment of anomocytic and 
anisocytic stomata with 
subsidiary cells 
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Powder Microscopy  
 
Under microscope shows numerous fragments of stone cells embedded with prismatic 
crystals of calcium oxalate; fragments of thick walled polygonal cork cells in surface view; 
fragments of bordered pitted vessels; numerous simple, irregularly ovoid or elliptical shaped 
starch grains with concentric striations having hilum in centre and sometimes compound with 
2-4 components measuring 12.2 to 51.8µ in diameter, numerous unicellular, uniseriate, warty, 
tubercles, pointed with basal in different sizes of trichomes; a few fragments of epidermis 
with anomocytic, anisocytic stomata and cicatrix; a few fragments of parenchyma cells; a few 
spherical shaped pollen grains with spines or warty surface; a few fragments of lignified 
spiral and reticulate vessels; a few fragments of non-lignified septate fibers; a few fragment 
of thick walled sclereid with narrow lumen and pits; a few fragments of parenchyma and 
annular vessels; a very few fragments of lamina with veins and vein- islets in surface view 
and a few entire seta. 
 
 
7.3 Physico-chemical Analysis 
 
Table: 2.Physico-chemical properties of  Seenthil Chooranam 
 
No Physico- Chemical Parameters Values 
1. 
Loss on drying at 105° C 10.30% 
2. Ash values 
a. Total ash    
b. Acid insoluble ash 
11.93% 
2.49% 
3. Extract values 
               a. Alcohol extract 
               b. Water extract 
13.76% 
21.02% 
4. 
PH 7.07 
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7.4 Determination of Microbial Load in Seenthil Chooranam 
 
Table: 3.Microbial load test results of Seenthil Chooranam 
 
7.5 Chemical analysis 
The Chemical analysis shows the presence of Silicate, Sulphate, Chloride, Calcium, 
Iron, Pottasium, Sodium, and Alkaloids in Seenthil Chooranam. 
 
                            Table: 4. Chemical Analysis of Seenthil Chooranam 
 
S.NO Parameters Results 
1. Silicate Present 
2. Sulphate Present 
3. Chloride Present 
4. Phosphate Absent 
5. Carbonate Absent 
6. Nitra Absent 
7. Sulphide Absent 
8. Oxalate Absent 
9. Nitrite Absent 
10. Borate Absent 
11. Lead Absent 
12. Copper Absent 
13. Aluminium Absent 
Interpretation 
 
The acidic radicals test shows the presence of Silicate, Sulphate and Chloride. 
S.No Parameters Results 
Permissible Limit 
for Internal use
R
 
1 Total Bacterial Count (TBC) 0.5x10
3
cfu/g 10
5
cfu/g 
2 Total Fungal Count (TFC) Less than 10 cfu /g 10
3
cfu/g 
3 Enterobacteriaceae Absent 10
3
cfu/g 
4 Escherichia coli Absent 10 cfu/g 
5 Salmonella Spp Absent Absent 
6 Staphylococcus aureus Absent  Absent 
7 Pseudomonas aeroginosa Absent Absent 
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Table: 5.Chemical Analysis of Seenthil Choornam 
 
S.NO Parameters Results 
14. Iron Present 
15. Zinc Absent 
16. Calcium Present 
17. Magnesium Absent 
18. Ammonium Absent 
19. Potassium Present 
20. Sodium Present 
21. Mercury Absent 
22. Arsenic Absent 
23. Starch Present 
24. Reducing sugar Absent 
25. Alkaloids Present 
26. Tannic acid Absent 
 
Interpretation 
 
The basic radical test shows the presence of, Iron, Calcium, Potassium, Sodium and 
Alkaloids and absence of heavy metals such as lead, arsenic and mercury. 
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7.6 TLC and HPTLC Results 
 
Table: 6. Rf. values for the alcohol extract 
 
S.No 254nm 366nm Dipped in Vanillin- 
Sulphuric Acid 
Colour Rf Colour Rf Colour Rf 
1 Green 0.12 Red 0.05 Grey 0.10 
2 Green 0.15 Red 0.12 Grey 0.14 
3 Green 0.34 Red 0.19 Dark Grey 0.34 
4 Green 0.39 Red 0.25 Dark Grey 0.44 
5 Green 0.44 Red 0.33 Grey 0.50 
6 Green 0.51 Violet 0.38 Grey 0.54 
7 Green 0.56 Red 0.42 Purple 0.58 
8 Green 0.59 Blue 0.47 Grey 0.76 
9   Red 0.54 Grey 0.84 
10   Red 0.58   
11   Yellow 0.72   
12   Blue 0.86   
13   Blue 0.95   
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TLC Photos 
 
    
  UV  254 nm     UV  366 nm 
  Figure no – 5.1    Figure no – 5.2 
                               
 
Derivatization with Vanillin-Sulphuric acid 
     Figure no – 5.3 
 
HPTLC finger print profile 
 
The finger print chromatogram was recorded at 254 nm. It showed 16 peaks of which two 
peaks at Rf. 0.12, 0.51 and 0.54 were major peak and others were moderately smaller peaks 
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Figure no – 6.1 
 
Rf Table for the HPTLC finger print: 
 
 
Figure no – 6.2 
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7.7 Heavy metal analysis 
 
Table: 7. Heavy Metals Analysis of Seenthil Chooranam 
 
S.No. Name of the Element Results Permissible Limit 
1 Lead 5.15 ppm 10 ppm (WHO) 
2 Cadmium Not Detected 0.3 ppm (WHO) 
3 Mercury 0.23 ppm 1 ppm (API) 
 
 
7.8 Elemental analysis 
 
Table: 8. Elemental Analysis of Seenthil Choornam 
 
S.no Elements Wavelength in  nm mg/L 
1 Arsenic As188.979 BDL 
2 Calcium Ca 315.807 07.390 
3 Cadmium Cd 228.802 BDL 
4 Copper Cu 327.393 BDL 
5 Iron Fe 238.204 18.346 
6 Lead Pb 220.353 BDL 
7 Mercury Hg 253.652 BDL 
8 Nickel Ni 231.604 BDL 
9 Potassium K 766.491 03.811 
10 Phosphorus P 213.617 76.341 
11 Sodium Na 589.592 14.310 
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7.9 HR SEM analysis 
 
HR SEM Micrograph of Seenthil Chooranam 
 
  
 
     Figure no - 07 
Inference: 
 The particles are in spherical form. 
 The particle size of Seenthil Chooranam ranges from 329.58 -366.2nm  
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7.10. ACUTE TOXICITYITY STUDIES 
Results: 
Wistar albino rat was treated with the test drug Seenthil Chooranam of single dose of 
2000mg/kg in melted ghee. This study was conducted as per the OECD guidelines. The result 
of acute Toxicityity of Seenthil Chooranam has been tabulated below 
 
Table: 9. Dose finding experiment and its behavioural Signs of Toxicityity 
 
No Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1 2000 + - - + + + - - - - - - - - - - - - - - 
 
1.Alertness 2.Aggressiveness 3.Pile erection 4.Grooming 5.Gripping 6.Touch Response 
7.Decreased Motor activity 8.Tremors 9.Convulsions 10.Muscle Spasm 11.catatonia 
12.Muscle relaxant 13.Hypnosis 14.Analgesia 15.Lacrimation 16.Exophthalmos 17.Diarrhoea 
18. Writhing 19.Respiration 20.Mortality 
 
(+) indicates the presence. 
(-) indicates the absence. 
 
Interpretation 
 The acute Toxicityity result shows no mortality rate up to dose level of 2000mg/kg. It 
showed changes in alertness, grooming, touch response and grip strength. The normal 
behavioural changes were observed in first four hours and no mortality was reported after 14 
Dayss observation. Hence the test drug Seenthil Chooranam is a safe up to the dose  of  level 
of 2000 mg/Kg in oral administration.  
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7.11 RESULTS OF REPEATED DOSE 28 DAYSS ORAL 
TOXICITYITY 
STUDY IN WISTAR RATS 
 
Table: 10. Changes of Body weight (g) of albino rats exposed to Seenthil Chooranam   
for 28 Dayss 
 
Treatment 0th Days 7th Days 14th Days 21th Days 28th Days 
Control 170.83±6.84 173.50±6.28 179.83±6.31 185.66±6.46 188.66±5.70 
Mid dose 163.16±6.38 163.33±6.60 167.83±6.610 171.16±7.32 174.83±7.37 
High dose  150.83±9.58 151.66±9.09 155.01±9.56 158.53±9.31 163.16±9.67 
 
Data are expressed as mean ± SEM (n = 10 for each group), *P < 0.05, **P<0.01 were 
considered significant using One way ANOVA followed by Dunnett’s test 
 
Chart- 01 
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Table: 11. Water intake (ml/Days) of albino rats exposed to Seenthil Chooranam  for 28 
Dayss 
 
Treatment 0th Days 7th Days 14th Days 21th Days 28th Days 
Control 30.0±0.48 32.16±0.22 34.13±0.33 35.2±0.16 35.46±0.34 
Mid dose 31.73±0.89 34.52±1.22 35.41±1.11 37.45±1.05 38.64±1.42 
High dose  32.66±1.15 35.01±1.64 38.33±1.77 40.16±1.43 40.5±1.52 
 
Data are expressed as mean ± SEM (n = 10 for each group), *P < 0.05, **P<0.01 were 
considered significant using One way ANOVA followed by Dunnett’s test 
Chart- 02 
 
 
 
Table: 12. Food (g/Days) intake of albino rats exposed to Seenthil Chooranam   for 28 
Dayss 
 
Treatment 0th Days 7th Days 14th Days 21th Days 28th Days 
Control 38.83±1.8 37.50±1.67 40.83±1.31 41.66±1.46 42.66±1.50 
Mid dose 40.16±0.38 42.33±0.60 42.83±0.61 43.16±1.32 44.13±1.37 
High dose  41.63±0.58 42.66±1.09 43.01±1.56 43.53±1.31 44.16±1.67 
 
Data are expressed as mean ± SEM (n = 10 for each group), *P < 0.05, **P<0.01 were 
considered significant using One way ANOVA followed by Dunnett’s test 
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Chart - 03 
 
 
 
Table: 13. Relative Organ Weight of albino rats exposed to Seenthil Chooranam   for 28 
Dayss 
 
Dose 
Relative Organ Weight of rats 
Liver Kidney Brain Lungs Heart Spleen Ovary Testis 
Control  
2.80±0.
1 
0.66±0.
02 
0.38±0.
22 
0.29±0.
01 
0.29±0.
01 
0.15±0.
01 
1.27±0.
01 
1.15±0.0
1 
Mid 
dose 
2.89±0.
1 
0.65±0.
02 
0.42±0.
01 
0.30±0.
02 
0.31±0.
01 
0.17±0.
01 
1.35±0.
01 
1.19±0.0
1 
High 
dose  
3.01±0.
1 
0.66±0.
03 
0.42±0.
01 
0.31±0.
01 
0.31±0.
01 
0.16±0.
01 
1.38±0.
01 
1.18±0.0
1 
 
Data are expressed as mean ± SEM (n = 10 for each group), *P < 0.05, **P<0.01 were 
considered significant using One way ANOVA followed by Dunnett’s test
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Table: 14. Haematological Parameter of Seenthil Chooranam 
 
 
Haematological parameter 
 
Control 
Seenthil Chooranam 
Mid dose High dose 
Total R.B.C. count (×10
6
 mm−3). 9.05±0.15 9.10±0.12 9.12±0.16 
TotalW.B.C. Count (×10
3
 mm−3). 12.67±0.22 12.12±0.48 11.23±0.12  
Haemoglobin (Hb) (g/dl) 15.61±0.36 14.87±0.27 15.48±0.78 
Platelets (×10
3
 mm−3). 834.91±24.01 845.21±16.55  863.58±16.25  
Lymphocytes(%). 77.7±1.32 79.28±2.63  78.8±5.49  
Neutrophils (%). 20.6±0.65 19.6±1.25 18.95±0.65  
PCV (%). 43.34±1.08 46.08±1.34 47.12±0.45 
MCV( fl) 54.34±5.17 55.58±1.83 55.17±2.79 
MCH (pg) 21.1 ± 0.4 20.2 ± 0.8 20.5 ± 1.3 
MCHC g/dl 36.81±3.41 34.55±1.18 36.12±2.17 
 
Data are expressed as mean ± SEM (n = 10 for each group), *P < 0.05, **P<0.01 were 
considered significant using One way ANOVA followed by Dunnett’s test 
 
The mean value of T.RBC of control and treated groups of wistar albino rats exposed to 
Seenthil Chooranam in Repeated Oral 28 DaysToxicity study. 
Chart - 04 
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The mean value of T.WBC and Platlets of control and treated groups of wistar albino 
rats exposed to Seenthil Chooranam  in Repeated Oral 28 DaysToxicity study. 
Chart - 05 
 
 
 
The mean value of Hb of control and treated groups of wistar albino rats exposed to 
Seenthil Chooranam  in Repeated Oral 28 Days Toxicity study 
Chart - 06 
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The mean value of Lymphocytes and Neutrophils of control and treated groups of 
wistar albino rats exposed to Seenthil Chooranam in Repeated Oral 28 Days Toxicity 
study. 
 
Chart - 07 
 
 
Biochemical Parameters  
 
Table: 15.  LFT results of wistar albino rats exposed to Seenthil Chooranam in Repeated 
Oral 28-Days Toxicityity study 
 Parameters  
Control 
Seenthil chooranam 
Mid dose High dose 
Total protein (gm/dl) 8.40±0.26 8.12±0.35 7.72±0.76 
Albumin (gm/dl) 4.40±0.41 4.30±0.35 4.26±0.26 
Globulin (gm/dl) 3.12±0.21 3.07±0.15 2.96±0.16 
AST (IU/L) 121.41±2.68 118.3±1.67 116.76±3.65 
ALT (IU/L) 69.40±1.57 69.01±2.32 68.62±3.28 
ALP (IU/L) 112.6±4.67 115.01±1.21 117.41±2.18 
T. Bilirubin (mg/dl) 0.25 ±0.32 0.3 ±1.12 0.37±01.82 
 
Data are expressed as mean ± SEM (n = 10 for each group), *P < 0.05, **P<0.01 were 
considered significant using One way ANOVA followed by Dunnett’s test 
0
10
20
30
40
50
60
70
80
90
Control Mid Dose High Dose
%
Lymphocytes and Neutrophils
Lymphocytes
Neutrophils
74 
 
The mean value of Total protein, Albumin and Globulin of control and treated groups 
of wistar albino rats exposed to Seenthil Chooranam  in Repeated Oral 28 DaysToxicity 
study 
Chart - 08 
 
 
The mean value of AST, ALT and ALP  of control and treated groups of wistar albino 
rats exposed to Seenthil Chooranam  in Repeated Oral 28 DaysToxicity study 
Chart - 09 
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The mean value of T. Bilirubin of control and treated groups of wistar albino rats 
exposed to Seenthil Chooranam  in Repeated Oral 28 DaysToxicity study 
 
Chart - 10 
 
 
 
Table: 16. Blood sugar and Lipid profile of wistar albino rats exposed to Seenthil 
Chooranam in Repeated Oral 28-Days Toxicityity study 
 
Parameters  
Control 
Seenthil Chooranam 
Mid dose High dose 
Glucose (mg/dl) 112.6±4.67 98.01±2.22* 88.41±3.28** 
Total Cholesterol (mg/dl) 49.60±1.21 51.46±1.08 50.83±1.05 
Triglycerides (mg/dl) 52.20±1.13 50.23±1.08 49.17±1.86 
HDL(mg/dl) 12.80 ± 2.70 11.5  ± 2.82 13.6 ± 1.64 
LDL(mg/dl) 39.5 ± 2.13 42.5 ± 2.11 43.2 ± 1.30 
VLDL(mg/dl) 14.05 ± 3.90 15.5 ± 2.04 15.9 ± 2.32 
 
Data are expressed as mean ± SEM (n = 10 for each group), *P < 0.05, **P<0.01 were 
considered significant using One way ANOVA followed by Dunnett’s test 
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The mean value of Glucose of control and treated groups of wistar albino rats exposed 
to Seenthil Chooranam  in Repeated Oral 28 Days Toxicity study 
Chart - 11 
 
 
The mean value of T.Cholesterol and Triglyceride of control and treated groups of 
wistar albino rats exposed to Seenthil Chooranam  in Repeated Oral 28 Days Toxicityity 
study 
Chart - 12 
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The mean value of HDL, LDL, VLDL  of control and treated groups of wistar albino 
rats exposed to Seenthil Chooranam  in Repeated Oral 28 Days Toxicity study 
 
Chart - 13 
 
 
Table: 17.  RFT results of wistar albino rats exposed to Seenthil Chooranam in Repeated 
Oral 28-Days Toxicityity study 
 
 
Parameters 
 
Control 
Seenthil Chooranam 
Mid dose High dose 
Creatinine (mg/dl) 0.58 ±0.07 0.65±0.04 0.54±0.11 
Urea (mg/dl) 15.30 ± 0.47 14.33±0.49 16.17±1.078 
Uric acid (mg/dl) 1.20±0.21 1.30±0.25 1.27±0.26 
 
Data are expressed as mean ± SEM (n = 10 for each group), *P < 0.05, **P<0.01 were 
considered significant using One way ANOVA followed by Dunnett’s test 
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The mean value of Creatinine, Urea and  Uric acid  of control and treated groups of 
wistar albino rats exposed to Seenthil Chooranam  in Repeated Oral 28 Days Toxicity 
study 
Chart - 14 
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HISTOPATHOLOGY OF VITAL ORGANS 
 
                       Control               High Power Magnification 40X        High Dose  
 
 
                            Brain                                 Figure 8.1                        Brain  
      
 
                           Heart                               Figure 8.2                        Heart  
  
  
 
 
Kidney                              Figure 8.3                        Kidney 
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Control               High Power Magnification 40X        High Dose 
 
 
                  
 
  
                           Liver                                 Figure 8.4                        Liver 
 
  
 
 
                         Lungs                           Figure 8.5                   Lungs 
 
Interpretation: 
 
Liver: 
Section of liver from control animals showed No degeneration of hepatocytes, focal steatosis, 
and congestion of central vein and inflammation of portal tract. 
Liver of treated groups showed No degeneration of hepatocytes, focal steatosis, and 
congestion of central vein and inflammation of portal tract  
 
Kidney: 
Section of kidney from control animals showed normal size of glomeruli with normal tubules. 
Kidney of treated animals showed normal glomeruli and there is no necrosis of tubular 
epithelium in the kidney. 
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Lungs: 
Section of lungs from control animal showed normal Normal architecture of a section and the 
drug treated group shows mild paraseptal thickening with inflammation 
 
Brain: 
Section of brain from control animals showed brain cortex with normal architecture. 
Treated animals showed brain cortex with normal architecture. 
 
Heart: 
Section of heart from control animal showed normal muscle fibers with acidophilic 
cytoplasm and centrally located nuclei  
In treated group showed normal muscle fibers with acidophilic cytoplasm and centrally 
located nuclei with normal structure. 
 
Heart, Lungs, brain, liver and kidney showed no cellular architecture in treated groups. From 
the histopathological study no related changes in vital organs are observed in treated groups. 
 
Results:  
All animals from control and all the treated dose groups survived throughout the 
dosing period of 28 Dayss for sub acute Toxicityity study. The results for body weight 
determination of animals from control and different dose groups show comparable body 
weight gain throughout the dosing period of 28 Dayss. During dosing period, the quantity of 
food and water consumed by animals from different dose groups was found to be comparable 
and normal with that by control animals. 
The results of haematological investigations conducted on Days 29
th
 Days revealed no 
significant changes in the haematological values when compared with those of respective 
controls. This gave clear justification that bone marrow and spleen were not influenced by 
Seenthil Chooranam. 
Results of Biochemical investigations conducted on Dayss 29 and recorded in 
revealed the no significant changes in the values of different parameters studied when 
compared with those of respective controls; Urea, SGOT,SGPT, Bilirubin were within the 
limits, blood glucose significant compared to control group.   
The other cardio vascular risk markers were also within normal ensured that Seenthil 
Chooranam did not influence the Cardio vascular system.  
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Group Mean Relative Organ Weights are recorded Comparison of organ weights of 
treated animals with respective control animals on Days 29 was found to be comparable with 
respective control group. Gross pathological examination of animals in control as well as the 
treated groups did not reveal any abnormalities.  
The vital organs such as liver, heart, kidneys, lungs and brain were removed from the test 
groups at the end of the study and carefully observed macroscopically to find any observable 
gross lesions compared with the control group and did not reveal any abnormal macroscopic 
changes. Gross pathological investigation was carried out and histopathology of vital organ 
reveled normal histological appearance when compared with the control. According to these 
results, Seenthil chooranam could be concluded as no-observed-adverse-effect level 
(NOAEL). It showed the safety of the drug which proved its utility in long time 
administration without any harm to the human being. 
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7.12 RESULTS OF REPEATED DOSE 90 DAYS ORAL TOXICITYITY 
STUDY IN WISTAR RATS 
 
Table 18: Changes of Body weight (g) of albino rats exposed to Seenthil Chooranam   for 
90 Days 
 
 
Data are expressed as mean ± SEM (n = 6 for each group), *P < 0.05, **P<0.01 were 
considered significant using One way ANOVA followed by Dunnett’s test 
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DAYSS 
GROUPS 
Control Low dose Mid dose High dose 
1 160.6±33.68 147.1 ± 21.11 155.6± 13.57 158.5± 28.75 
15 172.8 ± 28.87 161.5 ± 21.71 165.7 ± 29.01 165.8 ± 32.48 
30 180.8 ± 28.31 175.7 ± 14.88 180.8 ± 32.11 180 ± 28.94 
45 204.5± 27.73 194.5± 29.76 203.7± 19.75 207.3± 22.75 
60 217.6±33.68  213.6±23.68 225.6±33.68 214.6±23.78  
75 235.8 ± 26.85 225.8 ± 28.870 240.8 ± 28.87 223.8 ±26.87 
90 248± 27.320 238.5± 27.320 250.4± 27.32 236.3± 36.32
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Table 19: Haematological parameters of Wistar albino rats group exposed to               
Seenthil Chooranam. 
 
Category Control Low dose Mid dose High dose 
T.RBC 7.20±0.30 7.33±0.33 7.20±0.74 7.30±0.30 
T.WBC 
(cells/cu.mm) 
11.05±0.76 11.50±0.33 11.25±0.46 11.93±0.22 
Platelets 3.61±0.30 3.70±0.27 3.65±0.16 3.41±0.43 
PCV 37.74±.88 38.84±2.43 37.92±1.71 39.22±2.25 
Hb (%) 12.58±0.29 12.95±0.82 12.65±0.58 13.08±0.75 
MCV(%) 88.50±3.10 91.50±2.73 91.50±1.87 92.33±3.33 
MCH(%) 31.83±1.72 30.83±2.79 31.67±3.72 31.50±1.05 
MCHC 34.33±1.86 36.33±4.88 34.50±2.59 33.17±2.13 
 
Data are expressed as mean ± SEM (n = 6 for each group), *P < 0.05, **P<0.01 were 
considered significant using One way ANOVA followed by Dunnett’s test 
 
  
 
The mean value of T.WBC of control and treated groups of wistar albino rats exposed 
to Seenthil Chooranam 
 
Chart – 16 
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The mean value of Hb and T.RBC of control and treated groups of wistar albino rats 
exposed to Seenthil Chooranam 
 
Chart – 17 
 
 
 
 
The mean value of  Platelet of control and treated groups of wistar albino rats exposed 
to Seenthil Chooranam 
 
Chart – 18 
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The mean value of PCV, MCHC and MCV of control and treated groups of wistar 
albino rats exposed to Seenthil Chooranam 
 
Chart – 19 
 
 
 
 
Table 20: Biochemical Parameters of of Wistar albino rats group exposed Seenthil 
Chooranam 
 
BIOCHEMICAL 
PARAMETERS 
CONTROL LOW DOSE MID DOSE HIGH DOSE 
GLUCOSE (R) (mg/dl) 130.83±3.54 91.0±7.37* 81.83±8.18* 74.33±11.11* 
T.CHOLOSTEROL(mg/dl) 108.67±11.43 116.00±11.01 107.33±11.31 117.17±5.11 
TGL(mg/dl) 134.17±6.18 137.50±6.09 133.83±11.30 131.83±6.82 
HDL 39.00±6.13 43.67±2.80 43.50±3.78 44.67±8.09 
LDL 42.83±13.86 44.83±11.39 32.33±11.83 50.83±5.53 
VLDL 26.83±1.23 27.50±1.22 26.76±2.26 26.87.±1.64 
ALP 83.50±11.45 80.67±16.56 74.67±17.67 81.00±16.48 
 
Data are expressed as mean ± SEM (n = 6 for each group), *P < 0.05, **P<0.01 were  
considered significant using One way ANOVA followed by Dunnett’s test 
0
10
20
30
40
50
60
70
80
90
100
Control Low dose Mid dose High dose
PCV, MCHC  and  MCV 
PCV
MCHC
MCV
87 
 
The mean value of Blood sugar, Total cholesterol and Triglycerides of control and 
treated groups of wistar albino rats exposed to Seenthil Chooranam 
 
Chart – 20 
 
 
 
 
 
Table 21: Renal function test of of Wistar albino rats group exposed to                     
Seenthil Chooranam 
 
 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
UREA (mg/dl) 30.50±10.01 24.67±2.50 30.17±9.15 26.17±6.34 
CREATININE(mg/dl) 0.57±0.15 0.50±0.12 0.53±0.12 0.46±0.13 
 
Data are expressed as mean ± SEM (n = 6 for each group), *P < 0.05, **P<0.01 were 
considered significant using One way ANOVA followed by Dunnett’s test 
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The mean value of Urea and Creatinine of control and treated groups of wistar albino 
rats exposed to Seenthil Chooranam 
 
Chart – 21 
 
 
                                                                        
 
 
Table 22: Liver Function Test of of Wistar albino rats group exposed to   Seenthil 
Chooranam 
 
 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
T.BILIRUBIN(mg/dl) 0.58±0.15 0.48±0.07 0.66±0.16 0.76±0.12 
SGOT(U/dl) 24.00±2.28 25.83±2.92 27.83±4.66 24.67±3.67 
SGPT(U/dl) 23.33±6.37 24.50±2.73 25.33±2.66 23.33±5.20 
 
Data are expressed as mean ± SEM (n = 6 for each group), *P < 0.05, **P<0.01 were 
considered significant using One way ANOVA followed by Dunnett’s test. 
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The mean value of Total bilirubin, SGPT and SGOT of control and treated groups of 
wistar albino rats exposed to Seenthil Chooranam 
 
Chart – 23 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
5
10
15
20
25
30
Control Low dose Mid dose High dose
Total bilirubin, SGPT and SGOT 
Total bilirubin
SGOT
SGPT
90 
 
Histopathology of Control group animals 
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Figure 9.1 
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Figure 9.2 
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Liver 
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Figure 9.3 
 
Lung 
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Figure 9.4 
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Brain 
 
 
Low Power Magnification 10X           High Power Magnification 40X 
     
 
 
Figure 9.5 
 
 
 
Histopathology of High dosed group animals 
 
Heart 
 
Low Power Magnification 10X           High Power Magnification 40X 
              
Figure 9.6 
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Kidney 
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Figure 9.7 
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Figure 9.8 
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Lung 
 
   Low Power Magnification 10X           High Power Magnification 40X 
        
 
Figue 9.9 
 
 
Brain 
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Figure 9.10 
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Interpretation 
 
Kidney 
 Appearance of glomeruli, tubules, interstitium and lumen was normal in both the 
samples with no signs of degeneration  
 Interstitial connective tissue of both the sample appear normal 
Heart 
 Perfectly -arranged myocardial fibers, clear transverse striation and normal structure 
were observed. 
 Appearance of cardiomyocyte was normal with dark nuclear region. The nuclei of 
muscle fibers appear oval arrangement. 
Liver 
 Hepatocyte appears with dark pigment chromatin in centri lobular and periportal 
region 
 Hepatic sinusoid and hepatic cord was normal 
Lung 
 Lung parenchyma appears normal with regular arrangement of alveoli and alveolar sac 
with no signs of lymphocyte infiltration and pulmonary fibrosis 
 Perivascular region appears normal, Alveolar septa and wall appeared widen and normal 
 No signs of lymphocyte cuffing 
 No signs of airway secretion and bronchial secretion 
 Bronchial blood vessels and connective tissue appears normal with no sings of pulmonary 
edema 
Brain 
 Arrangement of the neurons appears intact with no sings of degeneration or apoptotic 
changes in both the samples 
 Cortex region showed normal neurons with polygonal to round cell bodies containing 
dense cytoplasm.No signs of ischemia or lesion were observed  
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Results & Interpretation of sub-chronic Toxicityity study: 
 
Sub-chronic oral Toxicityity repeated dose of Seenthil chooranam on rats were conducted. 
All animals from the treated dose survived throughout the dosing periodof 90 Dayss. Various 
parameters were studied and the interpretation of the study result is discussed below. 
 
Body weight 
 
The result of the body weight of rats exposed to control and the Seenthil chooranam of 
different dose groups exhibited overall weight gain throughout the dosing period of 90 Dayss. 
The quantity of food taken by the animals from different dose groups and the control is 
comparably normal. 
 
Haematological investigation interpretation: 
 
The haematological investigation results of the rats conducted on 91st   Days after the repeated 
dose of the drug revealed the values of different parameters.. The increase and decrease in the 
values obtained were all within the normal biological and laboratory limits. 
 
Biochemical investigation interpretation: 
The biochemical investigations were conducted on 90th Days and the result is produced. The 
results revealed there are no significant changes in the values of different parameters with 
that of the control. But sugar levels were reduced significantly. Other values were within the 
normal biological and laboratory limits. 
Gross & Histopathology 
 
Gross pathological examination of animals in control as well as the treated groups did 
not reveal any abnormalities.  
The vital organs such as liver, heart, kidneys, lungs and brain were removed from the test 
groups at the end of the study and carefully observed macroscopically to find any observable 
gross lesions compared with the control group and did not reveal any abnormal macroscopic 
changes. Gross pathological investigation was carried out and histopathology of vital organ 
reveled normal histological appearance when compared with the control 
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7.13 PHARMACOLOGICAL RESULTS OF ANTIDIABETIC ACTIVITY 
 
Tabl:23. Effect of Seenthil Chooranam on body weight, food and water intake in 
Streptozotocin induced diabetic rats 
 
Groups Body weight (g) Feed Intake (g/rat Per Days) Water Intake ( ml/rat per Days 
Intial  Final Intial  Final Intial  Final 
Group I 155.3± 4.05 168.3± 2.02 19.0± 1.52 22.66± 2.40 68.26± 4.48 64.48± 7.26 
Group II 152.6± 4.66 121.6± 3.75*** 22.12± 1.76 62.00± 3.46 
*** 
144.16± 6.14 174.26± 4.44 
*** 
Group III 146.8± 4.37 175.0± 2.88 *** 28.00± 1.15 33.82± 4.91 108.12± 1.14 80.98± 1.22 
*** 
Group IV 149.0± 3.51 155.0± 7.50 25.33± 1.76 29.33± 3.52 119.40± 3.16 158.16± 3.14 
*** 
Group V 140.0± 1.15 167.6± 1.45** 32.00± 2.30 43.33± 2.40 * 132.48± 4.09 148.14±3.12 
** 
 
Values are expressed as mean ± SEM of 6 animals. Statistical significance test for 
comparison between intial Vs final treatment between the groups was done by one way 
ANOVA followed by Dunnet’s  test. Whereas * p<0.05, ** p<0.01, ***p<0.001. 
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Oral glucose tolerance test: (OGTT) 
  
Normal rats were divided into four groups containing six animals in each group. 
All animals fasted before treatment. Group I was kept as vehicle control which 
received ghee, group II received Glibenglamide 5mg, group III received 
Seenthil chooranam 200 mg/kg, and group IV received Seenthil chooranam 400 
mg/kg respectively. All the rats were loaded with glucose (3 g/kg, p.o.) 30 
minutes after drug administration. Blood were collected and estimated. The 
blood glucose levels were determined by using glucometer by using strips 
Blood samples were collected from puncturing the retro orbital sinus just prior 
to drug administration, and 30, 60, 120 minutes after loading glucose
65
.  
 
Table: 24 Results of Oral glucose tolerance test (OGTT) 
 
Groups Oral Glucose Tolerance Test 
O min 30 min 60 min 120 min 
 Control 91.33± 1.76 131.16± 6.14 122.33 ±  5.20 112. 14± 3.78 
Glibenclamide 89.09± 4.65 114.56± 1.78 ** 98.66 ± 6.35 
*** 
86.33 ± 2.18 * 
S. Chooranam 
200 mg/kg 
88.16± 6.41 135.18± 3.24 
$
 120.66 ± 1.76 
***, 
$$
 
106.00 ± 2.30 
**,
 $$
 
S. Chooranam 
400 mg/kg 
91.16± 1.28 120.26± 6.24 ** 105.33  ± 2.40 
***, 
$$
 
94.00 ± 3.05 
***, 
$
 
 
Values are expressed as mean ± SEM of 6 animals. Whereas * p<0.05, ** p<0.01, 
***p<0.001 compared to control rats.
 $
 p<0.05, 
$$
 p<0.01, 
$$$ 
p<0.001 compared to 
glibenclamide groups was done by one way ANOVA followed by Tukey’s multiple 
comparison test.  
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Chart – 27 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Collection of blood and determination of glucose content  
For  blood  glucose  determination,  the  blood  was  obtained  by 
snipping  the  tail  by  means  of  a  sharp  razor.  Blood glucose level (BGL) 
was determined by means of a one touch horizon glucometer. Levels of glucose 
were expressed in mg/dl 
 
Table: 25. Estimation blood glucose level on different Days interval 
Groups Blood glucose (mg/dl) 
Days -0 Days -7 Days- 14 Days- 21 Days -28 
Control 101.9± 3.58  107.6± 3.62  118.6± 2.34  123.3± 4.23  121.8± 2.96  
STZ rats 421.0± 14.62 
***
  429.0± 3.08
***
  428.1± 
1.18
***
  
436.15± 
1.28
***
  
468.0±19.62
***
  
Glibenclamide 375.60± 1.82 
###  
342.0± 1.43 
### 
294.5± 1.32 
### 
239.71± 0.85 
### 
158.2±1.10 
###  
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S. Chooranam 
200 mg/kg 
383.0± 4.26 ### 360.0 ± 4.26 
### 
352.1± 
4.09##  
332.0 ± 1.23 
## 
310.0 ± 1.09 
### 
S. Chooranam 
400 mg/kg 
368.0 ± 2.28 
### 
354.0 ± 6.26 
### 
330.1 ± 2.16 
### 
318.0 ± 1.65 
### 
290.1  ± 1.64 
### 
 
Values are expressed as mean ± SEM of 6 animals. a- Group I Vs Groups II. Whereas * 
p<0.05, ** p<0.01, ***p<0.001. Whereas # p<0.05, ## p<0.01, ###p<0.001. b- Group II Vs 
Group III- V. Statistical significance test for comparison was done by one way ANOVA 
followed by Tukey’s multiple comparison test.  
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Estimation of biochemical parameters on Seenthil Chooranam in rats 
 
The SGOT, SGPT, creatinine, urea, uric acid, insulin were estimated in serum by kits 
specific for the test using autoanalyser. Serum insulin was determined by radioimmunoassay 
method
66 
 
Table: 26 Biochemical parameters on Seenthil Cooranam 
Groups Creatinine SGOT SGPT Urea Uric acid Insulin 
Control 0.46±1.22 45.00± 
1.73 
31.33±1.76 22.67±1.76 1.33±0.06 8.56±0.202 
STZ rats 0.93±0.12 
*** 
125.7± 
3.48 *** 
54.33±2.02 
*** 
98.67±1.76 
*** 
4.99± 0.15 
*** 
2.86±0.17 
*** 
Glibenclamide 0.40±1.31 
### 
52.00±1.15 
### 
28.00±1.15 
### 
28.00±0.57 
### 
1.43±0.09 
### 
7.76±0.08 
### 
S. Chooranam 
200 mg/kg 
0.59±1.018 
### 
72.67±2.90 
### 
34.67±2.667 
### 
72.33±1.45 
### 
3.40±0.28 
### 
5.70±0.15 
### 
S. Chooranam 
400 mg/kg 
0.50±2.01 
### 
58.67±1.76 
### 
32.00±2.30 
### 
42.00±5.29 
### 
2.53±0.14 
### 
6.86±0.17 
### 
 
Values are expressed as mean ± SEM of 6 animals. a- Group I Vs Groups II. Whereas * 
p<0.05, ** p<0.01, ***p<0.001. Whereas # p<0.05, ## p<0.01, ###p<0.001.b- Group II Vs 
Group III- V. Statistical significance test for comparison was done by one way ANOVA 
followed by Tukey’s multiple comparison test.  
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Table 27: Estimation of serum lipid profile on Seenthil Chooranam in rats 
 
 
Values are expressed as mean ± SEM of 6 animals. a- Group I Vs Groups II. Whereas * 
p<0.05, ** p<0.01, ***p<0.001. Whereas # p<0.05, ## p<0.01, ###p<0.001.b- Group II Vs 
Group III- V. Statistical significance test for comparison was done by one way ANOVA 
followed by Tukey’s multiple comparison test.  
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Treatment Total 
Cholesterol 
(mg/dL) 
Triglycerides 
(mg/dL) 
HDL 
(mg/dL) 
LDL 
(mg/dL) 
VLDL 
(mg/dL) 
Control 113.3± 5.69 130.7±2.40 63.33±2.40 31.33±1.76 26.00±2.30 
STZ rats 152.3±4.33 
*** 
161.3±4.80 
*** 
42.67±3.52 
** 
61.00±1.528 
*** 
32.67±4.05 
Glibenclamide 108.7±4.05 
### 
134.3±2.33 
### 
56.67±2.90 # 30.67±1.45 
### 
28.00±3.46 
S. Chooranam 
200 mg/kg 
116.7±2.40 
### 
148.7±1.76 45.67±2.02 28.67±1.76 
### 
25.33±2.02 
S. Chooranam 
400 mg/kg 
106.3±3.38 
### 
139.7±2.02 ## 52.00±2.30 21.00±1.15 
### 
27.33±3.18 
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Histopathology of pancreas 
Pancreatic tissues were fixed in 10% formalin, dehydrated with 50- 100% 
ethanol solution and embedded in paraffin. The section of 5µ m thick were cut 
and stained with haemotoxyllin eosin then examined under light microscope  
 
Group I- Normal   Group II- STZ treated rats 
    
 
Group III- STZ + Glibenclamid Group IV- STZ + S. Chooranam    
5mg/kg    200mg/kg 
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Group IV- STZ + S. Chooranam 400mg/kg 
  
 
 
 Group I- Normal Ghee treated rats showed using with Haematoxylin & 
Eosin stained section shows pancreas with normal islets and acini 
 Group II- STZ treated rats showed damaged and atrophic islet with acini. 
 Group III- STZ + Glibenclamide rats showed preserved and regenerated 
cells of islet with acini 
 Group IV- STZ + S. Chooranam 200mg/kg showed partial damaged of 
pancreatic islet cells.  
 Group V- STZ + S. Chooranam 400mg/kg showed small damaged and 
regenerating pancreatic islet cells 
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Interpretation of Anti-Diabetic activity  
The Anti-Diabetic Activity of the Seenthil Chooranam has been estimated in the 
streptozotocin induced diabetes in Wistar albino rat. Increase in blood glucose level is the 
important feature in diabetes. 
S.Chooranam at the dose of 200 mg/kg, 400mg/kg for four weeks were able to 
produce reduce the glucose level compared with streptozotocin treated Group. Experimental 
groups (III- V) were compared with diabetic control rats - Values are statistically significant 
at P<0.001. 
The diabetic hyperglycemia induces elevation of serum urea the results showed 
significant elevation in the levels of serum urea in the diabetic groups. The elevation of urea 
level observed in the diabetic rats was declined to normal by the administration of 
S.Chooranam at the dose of 200 mg/kg and 400mg/kg significantly. 
 
Concluaion : 
From these results, it could be concluded that the S.Chooranam is effective in the 
impaired diabetic renal function in addition to its hypoglycemic effect. 
 
  
111 
 
7.14 PHARMACOLOGICAL RESULTS OF HEPATOPROTECTIVE 
ACTIVITY 
 
.Table: 28 Effect of Seenthil Chooranam and Silymarin on haematological 
parameters of CCl4 induced liver damage in rats 
 
Parameters Control CCl4 CCl4+ S. 
Chooranam 
200 mg/kg 
CCl4+ S. 
Chooranam 
400 mg/kg 
CCl4+ 
Silymarin 
25 mg/kg 
PCV (%) 45.33± 
1.76 
22.67±1.76 
### 
29.67±1.20 32.33±2.02 
* 
34.67±1.76 
** 
Hb (g/dl) 16.00±0.57 10.60±0.70### 12.67±0.33 13.53±0.17 
** 
14.43±0.23 
*** 
RBC (x 
10
6
/µ L) 
7.33±0.17  5.00±0.11 ### 5.96±0.12* 6.033±0.18 
* 
6.433±0.26 
** 
Platelets (x 
10
3
/µ L) 
164.0±2.30  97.67±3.18 
### 
116.7±2.40 
** 
121.3±1.76 
** 
126.7±2.90 
*** 
MCV 63.67±0.88 41.33±3.52 
### 
47.00±2.08 51.33±1.20 
*  
54.00±2.00 
* 
MCH 24.33±1.85 14.33±1.20 # 13.67±0.88 15.33±1.76 16.67±2.40 
MCHC 35.00±1.73 45.00±1.73 # 41.67±0.81 40.67±2.18 36.67±2.40 
WBC X 10 
3
 
6.93±0.59 9.86±0.17*** 9.10±0.17 8.16±0.14 # 7.23±0.20 
### 
 
Values are Mean ± SEM; n = 6 animals in each group: 
≠P<0.05, ≠≠ P< 0.01, ≠≠≠ P<0.001 is 
considered significant when compared with group I; *P<0.05, **P< 0.01, ***P<0.001 is 
considered significant when compared with group II by Tukey multiple comparison test.  
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Table: 29 Effect of Seenthil Chooranam and Silymarin on serum enzymes 
(SGPT, SGOT and SALP), Total bilirubin and Total protein on CCl4 
induced liver damage in rats 
 
Values are Mean ± SEM; n = 6 animals in each group: 
≠
P<0.05, 
≠≠
 P< 0.01, 
≠≠≠ 
P<0.001 is 
considered significant when  compared with group I; *P<0.05,  **P< 0.01, ***P<0.001 is 
considered significant when compared with group II by Tukey multiple comparison test.  
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Group and 
Treatment 
Dose (mg/kg) 
SGOT 
(IU/L) 
SGPT 
(IU/L) 
SALP 
(IU/L) 
Total  
Bilirubin 
(mg/dl) 
TOTAL 
PROTEIN 
(mg/dl) 
Ghee 
10ml/kg 
62.00±8.08 34.67±4.66 22.67±2.40 1.63±0.58 15.33±1.76 
CCl4 
Rats 
1.25ml/kg (ip) 
167.3±34.65#
# 
119.3±14.89 
### 
41.33±1.76 
### 
10.03±1.20 
### 
3.66±0.88## 
Seenthil chooranam  
200mg/kg+ CCl4 
1.25ml/kg (ip) 
93.33±10.73 78.00±8.71* 28.67±1.76 
** 
7.33±0.35 7.66±1.20 
Seenthil chooranam  
400mg/kg+ CCl4 
1.25ml/kg (ip) 
 
76.67±6.36* 62.00±3.46 ** 23.33±2.40 
*** 
6.06±0.75* 9.33±0.88 
Silymarin 25 mg/kg 
25 mg/kg+ CCl4 
1.25ml/kg (ip) 
 
54.67±4.05 ** 56.67±4.66** 21.33±1.76 
*** 
3.46±0.40 
*** 
11.00±2.08 
* 
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Table: 30 Effect of Seenthil Chooranam and Silymarin on serum Creatinine 
and Urea, on CCl4 induced liver damage in rats 
 
 
Parameters Control CCl4 S. Chooranam 
200 mg/kg 
S. 
chooranam 
400 mg/kg 
Silymarin 
Creatinine 
(mg/dl) 
0.84±0.05 1.60±0.11 1.23±0.20 1.36±0.26 1.10±0.10 
Urea (mg/dl) 16.67±2.18 84.67± 4.80 
*** 
56.33±4.91 ## 43.00±4.35 
### 
35.33±4.80 
### 
 
Values are mean ± SEM. ***P<0.001, **P<0.01, *P<0.05 compared to control rats.### 
P<0.001, ##P<0.01, #P<0.05 compared with group II by Tukey multiple comparison test. 
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Histopathology of Liver 
 
Group 1: Control             Group 2 : CCl4treate
    
        
 
Group 3: S. Chooranam                         Group 4 : S.Chooranam 
     200mg/kg + CCl4              400mg/kg+CCl4 
        
 
 
Group 5: Silymarin 25mg + CCl4 
 
 
 Group1: Photomicrograph of liver tissue of control rats showing normal hepatic cells 
with central vein (CV) and sinusoidal dilation (S) 
 Group 2: Photomicrograph of liver tissue of rats treated with CCl4 showing severe 
Centrilobular necrosis (N) with disappearance of nuclei 
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 Group 3: Photomicrograph of liver tissue of rats treated with S. Chooranam at 
200mg/kg showing mild degree of necrosis (N) with mild inflammatory cells 
 Group 4: Photomicrograph of liver tissue of rats treated with S. Chooranam at 
400mg/kg showing normal hepatocytes with regenerating hepatocytes and mild 
inflammation in the portal area (M) 
 Group 5: Photomicrograph of liver tissue treated with Silymarin at 25mg/kg showing 
normal hepatocytes, portal vein (V) and portal artery 
 
Interpretation of Hepatoprotective activity 
 
The serum marker enzymes, SGOT, SGPT and SALP more specific index of liver cell 
damage and oxidative stress, which stimulate the release of amino transferases from 
hepatocytes into the blood. This study reveals that increase in the activity of the serum 
enzymes SGOT, SGPT and ALP were detected in mouse treated with CCl4 (Group II). 
However, the activities of these serum enzymes were significantly (P < 0.001) lower in 
treated with S.Chooranam (Group 3 and 4) than in Group II 
This present study confirmed in both the doses of S.Chooranam treatment (200 and 400 
mg/kg body wt.) significantly improved the effect of CCl4 induced liver damage. 
The Histopathological studies showed that CCl4 administered rat caused pathological 
changes in liver including severe centrilobular necrosis with disappearance of nuclei (Group 
2). The liver with mild change in showing mild degree of necrosis with mild inflammatory 
cells of rats treated with S.Chooranam 200mg/kg and CCl4 (Group3), the liver was almost 
has normal appearance of rats treated with S. Chooranam at 400mg/kg and CCl4 (Group4), 
showing normal hepatocytes with regenerating hepatocytes and mild inflammation in the 
portal area Indicating that the administration of S.Chooranam decreased the hepatocyte 
damage and silymarin also has the same effect (Group5). Control rats showed the normal 
appearance of liver without any histological alterations (Group1). 
Conclusion: 
In the present study the above parameters analyzed, it may concluded that S.Chooranam has 
Significantly produced hepatoprotective activity against CCl4 induced rat. 
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7.15PHARMACOLOGICAL RESULTS OF ANTI-INFLAMMATORY 
ACTIVITY 
 
 
Table: 31 Inhibitory effect of Seenthil Chooranam against carrageenin induced 
paw oedema in albino Wistar rats. 
 
Treatment Percentage of inflammation after carageenan injection at hr 
1 2 3 4 
Control 45.10±1.08 86.08±2.06 122.50±2.50 127.00±7.06 
S. Chooranam 
200mg/kg 
33.16±1.27 
$
 71.15±2.72  93.50±1.50 100.08±2.87  
S. Chooranam 
400mg/kg 
24.82±2.16 
*,  
65.16 ±1.14  71.10±1.18**,  81.00±0.72 
**,
 
 
Indomethacin 
10mg/kg 
16.74±7.26 
** 
34.12±4.34 
*** 
41.09± 2.26 
*** 
42.50±1.14 
*** 
 
  
 Values are Mean ± SEM; n = 6 animals in each group: 
* 
P<0.05, 
**
 P< 0.01, 
*** 
P<0.001 is 
considered significant when compared with control rats and followed by Two way ANOVA.  
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Results  
       Seenthil Chooranam 200 and 400 mg/kg doses of have demonstrated considerable anti-
inflammatory activity with the statistical significance of p<0.05 when compared to control 
rats. The Seenthil Chooranam at 400mg/kg dose have shown better anti-inflammatory 
response (p<0.01) control rats among the study doses and are shown in Table31.   
Conclusion: 
        Based on the results it can be concluded that the Seenthil Chooranam used in this study 
in different dose level were effective in the anti-inflammatory activity. 
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8.DISCUSSION 
 Qualitative, Quantitative, Toxicological and Pharmacological studies of Seenthil 
chooranam were performed in this study. Qualitative analysis includes pharmacognostical, 
chemical analysis and  Quantitative analysis using sophisticated analytical equipments such a 
AAS, ICP-OES, TLC/HPTLC and HR-SEM, besides that evaluation of acute, 28 days 
repeated oral dose toxicity,90 days repeated oral dose toxicity studies were carried out in 
Wistar albino rats as per OECD guidelines (423,407and 408respectively). And also the 
evaluation of Antidiabetic, Hepatoprotective and Anti-inflammatory activities were carried 
out in wistar albino models. 
 In physiochemical analysis the pH of the drug  Seenthil Chooranam was observed as 
7.07 (Table-1). It denotes it is slightly alkaline. Hence, in the oral administration of the drug 
it may indicates that the drug will get ionized in stomach and will be absorbed in intestine and 
directly sent to portal system.  
Loss on drying of Seenthil choorana m at 105ºC is 10.30 %( Table-1). It indicates the 
loss of volatile substances along with the water this reveals that drug will not lose much of its 
volume and volatile substance. It shows that the drug has more stability.  
Ash value 11.93 % (Table-1) it is the residue remaining after incineration that determines 
the inorganic substances present in the drug. Similarly it can also detect the nature of the material, 
whether it is adulterate or not. Hence, determination of the ash value provides an idea for judging 
the identity and purity of the drug 
The microbial load of the drug seenthil chooranam, the total bacterial count and 
fungal count are presence within the permissible limits. So, it is safe for the internal use. 
Qualitative Analysis of Seenthil Chooranam showed presence of Silicate, Sulphate, 
Chloride, Calcium, Iron, Pottasium, Sodium, and Alkaloids.(Table-4,5). 
By AAS the results of the trail drug seenthil chooranam possess that the heavy metals 
such as lead, cadmium, mercury are all detected within the permissible limits as per WHO 
guidelines.   
 In ICPOES analysis can conclude that the presence of the element such as arsenic, 
cadmium, copper, lead, mercury, nickel were determined as BDL as per WHO permissible 
limits in this Seenthil chooranam sample. Hence, it may be safe for human consumption. 
(Table-8). Also the study results exhibits that the presence of the elements in the sample such 
as phosphorus, iron, sodium, calcium, potassium  were observed  at the level of 76.341mg/L, 
18.346 mg/L, 14.310 mg/L, 07.390mg/L, 03.811mg/L respectively. The insufficient intake of 
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phosphorus leads to liver diseases normally. The drug seenthil chooranam rich in phosphorus 
thus can explain this drug may help in the treatment of liver diseases. 
TLC/HPTLC  is one of the important parameter used for detecting the adulteration 
for judging the quality of drugs. If the drug is adulterated there might be appearance of the 
other compounds present in adulterant, in turn may increase the number of spots and number 
of waves. (Table 06), Figure (5, 6) 
 HR SEM analysis of Seenthil chooranam reveals the particle size as -329.5 to 366.2 
nm. The particles are not arranged uniformly because can observe the aggregated particles in 
these SEM images of Seenthil chooranam sample. The aggregation of particles possess that 
the sample is in compound form. The particles are present in nano sizes thus can enhance the 
bioavailability of the drug (Figure 07).  
 In Acute toxicity study there is no mortality was observed in animals.  Based on 
OECD 423 the trail drug Seenthil Chooranam is considered as non toxic up to the dose of 
2000mg/kg.  
  Repeated oral toxicity study was conducted for about 28 days as per the OECD 
guideline-407 animals were observed throughout the period. The results of haematological 
investigations conducted on day 29
th
 day revealed no significant changes in the 
haematological values when compared with those of respective controls. This possesses clear 
justification that bone marrow and spleen were not influenced by Seenthil Chooranam. 
Results of Biochemical investigations conducted on days 29 and recorded in revealed 
the no significant changes in the values of different parameters studied when compared with 
those of respective controls; Urea, SGOT, SGPT, Bilirubin were within the limits, blood 
glucose significant compared to control group.   
Group Mean Relative Organ Weights were recorded Comparison of organ weights of 
treated animals with respective control animals on day 29 was found to be comparable with 
respective control group.  
The vital organs such as liver, heart, kidneys, lungs and brain were removed from the 
test groups at the end of the study and carefully observed macroscopically to find any 
observable gross lesions compared with the control group and did not reveal any abnormal 
macroscopic changes. Gross pathological investigation was carried out and histopathology of 
vital organ reveals normal histological appearance when compared with the control. 
According to these results, Seenthil chooranam could be concluded as No-Observed-
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adverse-effect level (NOAEL). It confirms the safety of the drug which proved its utility in 
long time administration without any harm to the human being 
Sub-chronic oral toxicity 90 days repeated oral dose of Seenthil chooranam on rats 
were conducted. All animals from the treated dose survived throughout the dosing period of 
90 days.  
The body weight of rats exposed to control and the Seenthil chooranam of different 
dose groups exhibited overall weight gain throughout the dosing period of 90 days. The 
quantity of food taken by the animals from different dose groups and the control is 
comparably normal. 
The haematological results were within the normal biological and laboratory limits. 
The biochemical results revealed there were no significant changes in the values of different 
parameters with that of the control. But sugar levels were reduced significantly compares to 
the control group, other values were within the normal biological and laboratory limits 
Gross pathological examination of animals in control as well as the treated groups did 
not reveal any abnormalities. The vital organs such as liver, heart, kidneys, lungs and brain 
were removed from the test groups at the end of the study and carefully observed 
macroscopically to find any observable gross lesions compared with the control group and 
did not reveal any abnormal macroscopic changes. Gross pathological investigation was 
carried out and histopathology of vital organ revealed normal histological appearance when 
compared with the control.  
The Anti-Diabetic Activity of the Seenthil Chooranam has been estimated in the 
streptozotocin induced diabetes in Wistar albino rat. Increase in blood glucose level is the 
important feature in diabetes. 
S.Chooranam at the dose level of 200 mg/kg, 400mg/kg for four weeks were able to 
produce reduce the glucose level compared with streptozotocin treated Group. Experimental 
groups (III- V) were compared with diabetic control rats - Values are statistically significant 
at P<0.001. 
The diabetic hyperglycemia induces elevation of serum urea the results showed 
significant elevation in the levels of serum urea in the diabetic groups. The elevation of urea 
level observed in the diabetic rats was declined to normal by the administration of 
S.Chooranam at the dose of 200 mg/kg and 400mg/kg significantly. From these results, it 
could be concluded that the S.Chooranam is effective in the impaired diabetic renal function 
in addition to its hypoglycemic effect. 
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The serum marker enzymes, SGOT, SGPT and SALP more specific index of liver cell 
damage and oxidative stress, which stimulate the release of amino transferases from 
hepatocytes into the blood.    
This study reveals that increase in the activity of the serum enzymes SGOT, SGPT 
and ALP were detected in mouse treated with CCl4 (Group II). However, the activities of 
these serum enzymes were significantly (P < 0.001) lower in treated with S.Chooranam 
(Group 3 and 4) than in Group II This present study confirmed in both the doses of 
S.Chooranam treatment (200 and 400 mg/kg body wt.) significantly improved the effect of 
CCl4 induced liver damage. 
The Histopathological studies showed that CCl4 administered rat caused pathological 
changes in liver including severe centrilobular necrosis with disappearance of nuclei (Group 
2). The liver with mild change in showing mild degree of necrosis with mild inflammatory 
cells of rats treated with S.Chooranam 200mg/kg and CCl4 (Group.3), the liver was almost 
has normal appearance of rats treated with S. Chooranam at 400mg/kg and CCl4 (Group.4), 
showing normal hepatocytes with regenerating hepatocytes and mild inflammation in the 
portal area indicating that the administration of S.Chooranam decreased the hepatocyte 
damage and silymarin also has the same effect (Group. 5). Control rats showed the normal 
appearance of liver without any histological abnormalities (Group. 1). 
In the present study the above parameters analyzed, it may concluded that 
S.Chooranam has significantly produced Hepatoprotective activity against CCl4 induced rat. 
       In anti-inflammatory activity the trail drug Seenthil Chooranam  at 200 and 400 mg/kg 
doses of have demonstrated considerable anti-inflammatory activity with the statistical 
significance of p<0.05 when compared to control rats. The Seenthil Chooranam at 400mg/kg 
dose have shown better anti-inflammatory response (p<0.01) control rats among the study 
doses and are shown in Table1 and Figure1.   
        Based on these results can conclude that the drug seenthil Chooranam showed potent 
anti inflammatory activity in various doses.   
 Based on the above results, It can be assumed that the Seenthil Chooranam has 
scientifically validated. 
  
Summary 
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9.SUMMARY 
 The test drug Seenthil Chooranam was selected from the siddha literature 
“Agasthiyar paripuranam – 400 -for its anti-Diabetic, Hepatoprotective and anti-
inflammatory activities. The dissertation started with an introduction explaining about 
the siddha concept, prevalence of diabetes and role of the test drug in treating 
diabetes. 
 The test drug was prepared properly by the given procedure. All the ingredients were 
identified and authenticated by the respective field experts. 
 Review of literature in various categories was carried out. Siddha aspect, botanical 
aspect and pharmaceutical review disclosed about the drug and the disease. 
pharmacological review was done to establish the methodologies. 
 The drug was subjected to analysis such as pharmacognostical, physicochemical, 
phytochemical, chemical and also the chemical finger print was engaged by using 
modern analytical techniques like Atomic Absorption Spectrometer (AAS), 
Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES) and  that the 
particle size and qualitative analysis of chemical elements of Seenthil chooranam  
were also assessed by Scanning Electron Microscope (SEM) which provided the key 
ingredients present in the drug thus it accounts the efficacy of the drug. 
 Toxicological study was made according to OECD guidelines comprising the acute, 
repeated dose 28-day oral toxicity and repeated dose 90-day oral toxicity study. 
Seenthil chooranam was confirmed as no-observed-adverse-effect level (NOAEL). It 
showed the safety of the drug which proved its utility in long time administration 
without any harm to the human being. 
 In conclusion, Seenthil chooranam was evaluated to be non-toxic in the tested doses 
and experimental states.  
 The final Discussion and conclusion chapters analyzed the dissertation. The 
conclusion chapter also provides a discussion of the verification and validity of the 
research results carried out. The most vital part of some experience of the findings in 
the dissertation is also discussed and thereafter invites the reader to further studies and 
future research possibilities.  
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 Pharmacological study was done. It revealed the Anti-diabetic, Hepatoprotective and 
Anti-inflammatory activities in animal model Wistar albino rats. This present study 
suggests Seenthil Chooranam has remarkable medicinal value in the treatment of 
Diabetis and Liver diseases. 
 Results and discussion gives the necessary justifications to prove the potency of the 
drug. 
 Conclusion gives a compiled form of the study and explains the synergistic effect of 
all the key ingredients and activities that supports the study.  
 Thus the herbal formulation Seenthil Chooranam is validated for its safety and 
efficacy for treating diabetes mellitus and Liver diseases it would be a great drug of 
choice. 
 
 
   
Conclusion 
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10.CONCLUSION 
 
 Seenthil Chooranam was prepared as per the siddha literature. 
 When it was subjected into analysis it fulfills all the standardization parameters of 
chooranam as mentioned in AYUSH guidelines 
 From the results of SEM images it confirms the spherical shape and aggregated 
particle morphology obtained for this Seenthil Chooranam sample. 
  Based on OECD 423 the trail drug Seenthil Chooranamis considered as non toxic up 
to the dose of 2000mg/kg. This observation reveals that the LD50 of Seenthil 
chooranam is greater than 2000mg/kg 
 Seenthil Chooranam could be confirmed as no-observed-adverse-effect level 
(NOAEL) drug as it acts harmlessly under the current normal usage and this 
phenomenon is considered to be non toxic. 
 The Anti-Diabetic, Hepatoprotective and Anti-Inflammtory activity of 
SEENTHIL CHOORANAM was scientifically validated in animal models. 
 Hence, it can be concluded as a therapeutically effective drug in Diabetes and Liver 
diseases by further evaluation. 
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